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Brucella abortus is a Gram negative intracellular pathogen that causes the zoonotic disease 
brucellosis. Antibiotic treatment for brucellosis in humans is prolonged and sometimes followed 
by relapses. Currently, the United States employs prevention of the illness in humans through 
cattle vaccinations, eliminating the bacterium in its natural host. Unfortunately, these vaccine 
strains cause the disease in humans, and Brucella research ultimately aims to identify new 
vaccine targets as well as alternative treatment options.  
Brucella abortus resides in the phagosomal compartment of the host macrophage where 
essential nutrients such as iron are limited. Most bacteria need iron, and within the macrophage, 
heme is a likely source of iron due to the breakdown of red blood cells by the host macrophage. 
Heme transporters in Gram negative bacteria are highly conserved, and include components for 
outer membrane, periplasmic, and cytoplasmic membrane transport. BhuA has been previously 
characterized as the outer membrane heme transporter of Brucella abortus and here we report 
that BhuT, BhuU, and BhuV (BhuTUV) are the periplasmic and cytoplasmic heme transport 
components and that they are required in order for Brucella abortus to transport heme as an iron 
source. Utilization of heme as an iron source requires the breakdown of heme into ferrous iron, 
 carbon monoxide, and biliverdin by a heme oxygenase. BhuO has been identified as a heme 
oxygenase in Brucella abortus, and although there seems to be more than one heme oxygenase in 
Brucella, this study shows that BhuO is needed for the use of heme as an iron source under iron 
starvation conditions in vitro. Further, both bhuTUV and bhuO are regulated in an iron-
responsive manner. The iron responsive regulator Irr directly represses bhuO, which shares an 
operon with rirA. Then the rhizobial iron regulator RirA in turn represses the bhuTUV operon. 
Together, these regulators help to maintain iron homeostasis within the bacterial cell, protecting 
it from damaging hydroxyl radicals produced by Fenton chemistry. 
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Chapter 1: Literature Review 
Brucella  
The causative agent of brucellosis 
Brucella spp. are Gram negative pathogens that belong to the phylogenetic branch of the 
alpha proteobacteria, which encompasses a large variety of organisms, including other 
pathogenic bacteria, such as Bartonella quintana as well as  Rhizobium leguminosarum, a 
bacterium that has adapted a symbiosis with its plant hosts (Williams 2007). Despite their 
apparent differences, many of the bacteria within this grouping share similar t raits. For instance, 
several species within the alpha proteobacteria develop chronic, long term relationships with 
higher eukaryotic organisms (Batut 2004). In fact, the ability to evade the immune system and 
establish a chronic infection is the key factor in Brucella virulence (Barquero-Calvo 2007). 
 Brucella are found within a wide variety of animal reservoirs, with the individual strains 
named according to their natural hosts. B. ceti is found in porpoises and dolphins, B. 
pinnipedialis is found in seals, and B. microti is found in voles and red foxes (Pappas 2010). 
While there are many different species of Brucella, the three primary species that cause zoonotic 
infections in humans are B. melitensis, B. abortus, and B. suis strains which naturally infect 
goats, cattle, and swine, respectively (Solera 2010).  
Humans are not a natural host for Brucella strains, and human brucellosis is strictly a 
zoonotic disease. Within the context of their animal hosts, most of these strains cause abortion 
and infertility, however, the symptoms are more flu-like in humans, characterized by a spiking 
and remitting fever and general malaise (Spera 2006). Due to the generalized nature of the 
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symptoms of brucellosis in humans, diagnosis is often slow, and in spite of heavy, sustained 
antibiotic treatment such as a combination of rifampin and doxycycline for six weeks, there is a 
10-30% relapse rate (Skendros 2006). Since treatment of human brucellosis is not always 
effective, prevention is the best course of action. 
Human consumption of unpasteurized milk from a diseased animal is a real problem in 
endemic areas of the world (Pappas 2010), and human brucellosis is a common occurrence; 
however, in the United States a successful vaccination program has led to the eradication of the 
disease in food animals. The vaccines used to control the disease in animals are RB51 and strain 
19 in cattle, and in other parts of the world, Rev1 in sheep and goats (Ko 2003). Unfortunately, 
these vaccines cause the disease in humans, and to date there are no known human vaccines for 
the prevention of brucellosis (Olsen 2006). Therefore, the best prevention available is to keep our 
food animals brucellosis-free. Unfortunately, there is a large wildlife population that still carries 
Brucella species, and occasional interaction between livestock and these diseased animals can 
result in reintroduction of brucellosis to the unvaccinated mammals (Pappas 2010).  
Cattle are the natural host of Brucella abortus, and within this host the brucellae establish 
either a chronic infection or, in a pregnant cow, an acute infection (Detilleux 1990). Brucella 
resides within the cells of its host, leading to evasion of the host immune response (Detilleux 
1990). During an acute infection, the brucellae reside within the placental trophoblast epithelial 
cells, living on the unique erythritol carbon source that is only made during the third trimester in 
ruminants, which results in the third trimester abortion of the fetus (Acha 1980). Erythritol is the 
preferred carbon source for Brucella, and erythritol catabolism in Brucella is heavily iron-
dependent, which greatly increases the cell’s iron requirement as cofactors in this reaction 
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(Sperry 1975). The brucellae in this niche replicate in large numbers within the placental 
trophoblast, causing abortion. For the establishment of a more chronic infection in cattle, the 
brucellae take up residence within the bovine macrophages. Because erythritol is not found in 
humans, humans tend to develop a more chronic infection, and the ideal environment in this 
niche for the brucellae is within the macrophage (He 2006).  
While most pathogenic bacteria rely on classical virulence factors such as toxins, 
pathogenicity islands and virulence plasmids, Brucella species utilize a more subtle approach to 
establishing and maintaining infection within their host. In fact, Brucella pathogenesis is mainly 
based on its ability to survive and multiply within the host macrophages.  One coined term, 
“virulome” is used to describe the set of genes needed for survival of Brucella in the 
macrophages (Köhler 2002). The virulome genes are often associated with metabolism, and 
transposon mutagenesis of the Brucella chromosomes led to striking attenuation of the mutants 
in which amino acid biosynthesis genes were disrupted. This suggests that these corresponding 
metabolites are not available in the phagosomal compartment. Other attenuated mutants involved 
genes that are associated with cellular stress response, such as hfq and rsh (a rel/spoT homolog), 
and these mutations resulted in lowered resistance to stress induced by peroxides and acidic 
conditions. These results collectively lead to the conclusion that the Brucella environment is low 
in nutrients and oxygen (Köhler 2002). Therefore, it is important to take a closer look at the 
Brucella genes associated with nutrient uptake and metabolism in order to better understand the 
pathogenic nature of this bacterium. 
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A stealthy intracellular pathogen 
Animal models of infection using mice and natural hosts (goats and cattle) have been 
developed (Kahl-McDonagh 2007) in order to gain a better understanding of what takes place 
during infection of a mammalian host with brucellae. Two popular mouse models are Balb/c 
mice and C57BL/6 mice. These mice strains provide different immunological responses to 
Brucella infection, with the C57BL/6 strain producing a more effective, cell-mediated response 
than Balb/c mice (Silva 2011). These differences have provided key insights into understanding 
the host immune response and have helped to reveal the relationship between cell-mediated Th1 
host response and clearance of the brucellae organisms in vivo. The Th1 immunologic response 
of the C57BL/6 mice often results in clearance of the wild type brucellae after 2 months of 
infection, whereas the Th2 immunologic response of the Balb/c mouse during Brucella infection 
is ineffective and brucellae organisms may persist for over 6 months in vivo. It has been shown 
throughout the literature that the cell-mediated immune response (Th1), and not the humoral 
immune response (Th2), is required for an effective clearance of Brucella organisms that have 
chronically infected the host (de Jong 2010). 
Brucella are extremely stealthy, and both avoid and suppress the host innate immune 
response (de Jong 2010). Brucella enter their host mostly through a mucosal route, via ingestion 
or inhalation, where they first encounter the host immune system. The O-chain component of the 
Brucella LPS interacts with the surface of the macrophage, allowing for unopsonized entry of the 
brucellae into these cells (Porte 2003). This intracellular niche protects the Brucella from 
complement and antibodies; however, even those brucellae that have not yet made it to their 
intracellular niche have ways to avoid the immune response. Most notably, the 
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lipopolysaccharide (LPS) of Brucella triggers an ineffective Th2 immunological response. The 
pathogen- associated molecular patterns (PAMPs) often recognized by the host toll – like 
receptors (TLRs) do not bind very well to the LPS of Brucella. For instance, the lipid A of 
Brucella contains a very long fatty acid residue that is not recognized well by TLR4, allowing 
the bacteria to avoid induction of a strong inflammatory response (Lapaque 2006). Also, the 
perosamine O-chain of the Brucella LPS is not broken down well by macrophages, and it forms 
complexes with MHC class II molecules, inhibiting their ability to present antigens for further 
host immune activation (Forestier 2000). Additionally, because of its aberrant O-antigen, 
Brucella LPS does not interact very well with C3 of the host’s pro-inflammatory complement 
system, which also interferes with a robust response to infection (Hoffmann 1983).  
In addition to having low TLR agonist and complement activity, Brucella produces 
proteins that interfere with the host immune signaling. TcpB contains a Toll/interleukin-1 (TIR) 
domain that blocks TLR2 and TLR4 – mediated induction of NF-kB expression by inducing the 
degradation of MAL, which reduces the ability of the host cell to produce proinflammatory 
cytokines such as TNF-α and IL-12 (Salcedo 2008). PrpA is a proline racemase produced by 
Brucella that stimulates the production of IL-10, an anti-inflammatory cytokine (Spera 2006). 
All of these initial evasions of the host innate immune response are vital to the establishment of 
infection. 
Intracellular survival for the brucellae is not quite so stealthy, however, and within 
phagocytic cells about 90% of the bacteria are immediately killed by the oxidative burst of the 
macrophage (Jiang 1993). However, a small population of brucellae that enter the host survive, 
and it is with these successful pathogens that our interest lies.  
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Research to date has revealed a high level of interaction between the host and Brucella 
pathogen during the establishment and maintenance of chronic infection. A successful brucellae 
is able to resist being digested in the cellular phagosome, which temporarily fuses with the 
lysosome and acidifies, escape constitutive phagosomal fusion with the lysosome, and move to 
the safer compartment of the endoplasmic reticulum (ER), where it is able to replicate. Brucella 
strains enter the cell within a phagosomal compartment referred to as the Brucella-containing 
vacuole (BCV) (Celli 2005). The BCV interacts with early endosomal compartments, taking on 
several endosomal markers and causing acidification of the BCV (Bellaire 2005). The BCV 
quickly (10 minutes) loses its endosomal markers and takes on more lysosomal – like markers, 
such as Lamp-1, which remain detectable for up to 4 hours postinfection (Starr 2008). 
Simultaneously, the macrophage begins to express a natural resistance - associated macrophage 
protein -1 (Nramp1) within the membrane of the BCV. Nramp1 is a divalent cation transporter 
that creates an efflux of these precious nutrients from the phagosomal compartment, and is a vital 
protein for cellular resistance to S. enterica serovar Typhimurium, Leishmania donovani, or 
various species of Mycobacterium (Vidal 1995). This is a critical time for the brucellae, and they 
must survive in this extremely low- nutrient, acidic compartment. However, these harsh events in 
the BCV are necessary for Brucella survival, and it is this drop in pH and nutrients that signals 
Brucella to express genes to assemble the type IV secretion machinery (Porte 1999). The type IV 
secretion system releases effectors that are responsible for the BCV progression to the ER niche, 
and Brucella strains that lack a functional type IV secretion system are digested before they 
reach the ER (Celli 2003). At this point, the fusion between the BCV and the ER ensures the 
success of the brucellae, since this is a safe niche where it can replicate (Celli 2006).  
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The bacterial necessity for iron 
The chemistry of iron 
Iron, the most common metal on earth, is an essential metal for most living organisms. 
While iron can exist in an extensive range of oxidation states, the most common, biologically 
relevant forms are Fe
2+
 (ferrous) and Fe
3+
 (ferric). Ferric iron, which is insoluble at neutral pH, is 
predominantly found in the environment, and the ferrous form is typically found in environments 
low in either oxygen or pH (Rajasekaran, 2010). It is because of the ability of iron to alter its 
redox state that it is used as the catalytic site for many different proteins (Waldron, 2009). The 
reactivity of iron is a double – edged sword, however, since iron can also convert oxygen to 
reactive species (ROS). The Haber – Weiss reaction describes the interaction of ferrous iron with 
hydrogen peroxide. The product of this reaction is ferric iron, a hydroxyl radical, and a hydroxyl 
anion (Haber, 1932). Furthermore, the Fenton reaction involves ferric iron reacting with 
hydrogen peroxide to yield ferrous iron, a peroxide radical, and a proton (Fenton, 1894). The end 
result of these two reactions, commonly known as Fenton chemistry, is the production of very 
reactive, damaging hydroxyl radicals from the cyclic interaction of both forms of iron with 
hydrogen peroxide. 
(1) Fe
2+
 + H2O2 → Fe
3+
 + OH· + OH
−
 
(2) Fe
3+
 + H2O2 → Fe
2+
 + OOH· + H
+
 
The hydroxyl radical is remarkably reactive and damaging to cellular components, and it can 
cause the potential for further damage by freeing iron from Fe-S centers of proteins and from the 
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iron storage protein ferritin (Arosio, 2009). Superoxide and ascorbate can also reduce ferric iron 
to its ferrous, reactive form (Kell 2010). Among other things, these hydroxyl radicals also react 
with DNA, causing damage that can lead to cell death (Loft 1996 and Lloyd, 1998). 
Iron participates in a substantial number of cellular processes, including respiration, the 
tricarboxylic acid (TCA) cycle, oxygen transport, lipid metabolism, DNA synthesis, and gene 
regulation (Cairo 2006).  Because iron is redox reactive, it is the metal commonly used in the 
active site of many important cellular respiration enzymes, such as cytochromes (Massey, 1963). 
In the TCA cycle, iron is needed for the aconitase enzyme, a critical enzyme in this metabolic 
pathway (Glusker, 1968). Iron also forms complexes with molecular oxygen in hemoglobin and 
myoglobin, both proteins are involved in oxygen transport within mammals (Perutz, 1960). In 
fact, within the host, heme is often the main source of iron. Heme consists of a tetrapyrolle ring 
surrounding an iron center, and is itself a very toxic molecule (Kumar 2005). Free heme damages 
lipids, proteins, and DNA through the generation of reactive oxygen species (Schmitt 1993). 
Heme and heme proteins have been implicated in a variety of toxic effects through the oxidation 
of lipids. Heme can aggregate in the cell membrane and promote oxidation, leading to the 
enhancement of permeability and membrane disruption, which may cause cell lysis. 
Bacterial adaptations to the chemistry of iron 
Bacterial iron metabolism encompasses three major processes: acquisition, storage, and 
release. The overall goal of these processes is to create and maintain iron homeostasis on a 
cellular level, since either too much or too little iron can wreak havoc on the survival of the 
organism. Bacteria acquire iron through specific transport systems (detailed later); any unused 
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iron must be either stored immediately or released out of the cell in order to protect the cell 
against the dangerous reactivity of iron. 
Bacteria contain three types of iron storage proteins, the non-heme iron containing 
ferritin, the heme-containing bacterioferritin and a smaller protein, Dps (Andrews 1998). Ferritin 
contains 24 subunits that make up a protein “nanocage”. Its center contains a ferroxidase activity 
that catalyzes the oxidation of ferrous iron to its ferric form, at least initially, as the iron core 
builds up. Likewise, bacterioferritin is very similar to ferritin and contains 24 heme molecules 
per holomer. Although research is still very active in this area, it is believed that a bacterioferritin 
associated ferroxidase (Bfd), which is genetically coded next to bfr in many bacteria, resides at 
the center of Bfr, performing a similar ferroxidase activity to that found in ferritin, within this 
protein aggregate by catalyzing the oxidation of ferrous iron (Hawkins, 1996). Dps forms smaller 
spherical cages made up of 12 subunits that can also function as a reservoir for iron (Andrews 
1998). 
Bacterial iron export is a fairly new area of research, with the recent identification of FieF 
in E. coli as a ferrous iron efflux pump fueled by the respiratory chain (Grass 2005), and a 
protective function against heme toxicity attributed to the product of ght in Neisseria 
meningitidis, which may be working as a heme exporter (Rasmussen 2005). Most recently, a 
TolC-dependent efflux system in E. coli has been shown to export porphyrins to avoid a toxic 
accumulation (Tatsumi 2008). Due to the toxic nature of both iron and heme, it is believed that 
more such protective export systems will be discovered in the near future. 
Thus far emphasis has been placed on the importance of iron and heme storage and efflux 
in bacterial cells, however, as before mentioned, excessive iron in the cell interacts with 
10 
 
hydrogen peroxide, resulting in the production of toxic hydroxyl radicals. Therefore, iron uptake 
must be tightly regulated in order to maintain a delicate balance of iron within the cell. In the 
majority of Gram negative bacteria, the genes encoding iron uptake systems are regulated by the 
ferric iron uptake (Fur) regulator (Szafran 2008). Fur acts as a negative regulator of transcription 
by forming a dimeric complex with ferrous iron and binding specific sites within the promoter 
region of the target operon, blocking access by the transcriptional machinery. Therefore, when 
there is sufficient iron in the cell, Fur represses iron acquision genes. The equivalent iron – 
dependent regulator in some Gram positive bacteria like Corynebacterium diphtheriae is DtxR 
(Boyd 1990). DtxR was originally shown to regulate toxin production, but it also regulates the 
heme oxygenase genes in these organisms (Qian 2002). Interestingly, in the Gram negative alpha 
proteobacteria, Fur regulates manganese uptake genes, not iron metabolism genes, and is called 
Mur (manganese uptake regulator) (Rudolph 2006). The Brucella abortus Mur has recently been 
shown to regulate the manganese transporter mntH (Menscher 2012). 
Instead of Fur, growing evidence implicates two regulators with a high degree of 
interplay in the alpha proteobacteria, RirA and Irr, in the iron – responsive regulation of iron 
metabolism genes. Originally found in Rhizobium leguminosarum, the rhizobial iron regulator 
(RirA) is a member of the Rrf2 family of regulators. Rrf2 itself regulates cytochrome 
biosynthesis in Desulfovibrio while IscR, another regulator of this family found in E. coli 
regulates the synthesis of iron-sulfur clusters (Johnston 2007). RirA can have both positive and 
negative effects on iron metabolism genes, and although it is not thought to directly bind iron 
like Fur does, it does contain an iron-sulfur center (Todd 2005). The iron-responsive operator 
(IRO) is the conserved sequence motif that RirA is proposed to bind, since mutation of this IRO 
box eliminates the iron responsive repression of the iron gene being studied (Yeoman 2004). To 
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date, RirA has been shown to regulate a variety of genes involved with iron uptake, energy 
metabolism, and heme biosynthesis (Rudolph 2006) (see Figure 1.2). 
While RirA is more “Fur-like” in nature, its role in iron regulation appears to be minor in 
the alpha proteobacteria when compared with that of Irr. Whereas RirA senses cellular iron in the 
form of FeS clusters, Irr, an iron response regulator (Irr) first found in Bradyrhizobium 
japonicum (Hamza 1998), senses the metabolic intracellular concentrations of iron through direct 
interaction with heme molecules. Ferrochelatase is the last enzyme of the heme biosynthesis 
pathway, inserting an iron molecule into protoporphyrin IX to create heme. Irr binds to 
ferrochelatase in the absence of heme, however it is displaced in the presence of iron. The 
binding of the newly synthesized heme to Irr causes the protein to degrade, and therefore Irr is 
only present under iron limiting conditions (Qi 1999). Under iron limiting conditions, Irr 
represses the transcription of the heme biosynthesis genes, since heme biosynthesis requires iron, 
and at the same time increases the transcription of iron acquisition genes. 
Bacteria compensate for iron starvation both by inducing iron transport systems and by 
decreasing the cell’s iron demands, and in the alpha proteobacteria, Irr functions in both of those 
roles (Rudolf 2006) (see Figure 1.2). For example, under iron limited conditions, Irr 
transcriptionally represses the biosynthesis of heme, thus reducing the cell’s iron needs 
(Martinez 2005). Under iron limitation, Irr also increases the expression of catechol siderophore 
and heme uptake genes, which allows the cell to bring in more iron (Martinez 2006, Anderson 
2011). Irr only functions under low iron conditions, since the Irr protein is degraded in the 
presence of sufficient iron levels (Rudolf 2006). Irr binds to motifs known as iron control 
element (ICE) boxes within the promoter regions of several iron and heme responsive genes 
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(Rudolf 2006b), and Irr is implicated in the regulation of a growing number of iron transport 
genes of Brucella, including bhuA, the outer membrane heme transporter (Anderson 2011).  
RirA primarily functions under sufficient iron conditions, whereas Irr is only present 
when cellular iron levels are low. The interplay of the RirA and Irr regulators allows for fine-
tuning of cellular regulation of not only iron and heme, but also those genes inevitably affected 
by iron levels such as those genes implicated with the oxygen and carbon utilization and cellular 
stress (Johnston 2007). As a result, in high iron medium RirA will be more repressive due to the 
accumulation of FeS clusters and Irr will be less so, because the increased heme levels will lead 
to degradation of this regulator. However, under iron limited conditions, Irr would be the major 
player, allowing for transcription of genes both bringing in more iron and repressing the cell’s 
iron needs.  
 Another heme – sensing regulator of iron metabolism genes is the two component 
system ChrSA, first discovered in Corynebacterium to positively regulate the heme oxygenase 
gene (Schmitt 1999) as well as an ABC transporter, HrtAB, that protects the cell against heme 
toxicity (Bibb 2010). In Brucella abortus, the chrSA genes are operonic and are predicted to 
encode a sensor kinase (ChrS) and a cognate response regulator (ChrA). Preliminary data 
suggests that both iron- and heme- responsive transcription of the genes encoding the outer 
membrane heme transporter are dependent on ChrA in Brucella, suggesting a similar role for 
ChrSA in this organism (Paulley 2007 dissertation). Ongoing experiments will tell us if ChrSA is 
truly a heme responsive regulator. 
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Availability of iron within the host 
Iron trafficking in the host 
Because iron is a necessary nutrient for most organisms, there are many different 
methods employed by host cells to take up iron. Systemically, within mammals, dietary iron is 
absorbed into the luminal side of duodenal enterocytes of the gut. Ferric iron must be reduced to 
ferrous iron in order to be transported across the cell membrane. Dcytb is a ferric reductase that 
often performs this function (Wyman 2008). The ferrous iron is then transported across the 
membrane by DMT1 (Cannone-Hergocts 2001). Moreover, heme constitutes a minor part of 
dietary iron, but it is transported very efficiently through the host cell membrane by HCP1 
(Shayeghi 2005).  
The diffusion of Fe
2+
 across the basolateral membrane of the duodenal enterocyte and 
into the blood is assisted by iron-regulated transporter 1 (IREG1), a transmembrane iron 
transporter protein (McKie et al., 2000). Hephaestin, a membrane-bound protein, promotes 
oxidation of Fe
2+
 to Fe
3+
 (Vulpe et al., 1999). Once it is exported, this ferric iron is promptly 
bound to apotransferrin and circulated in the blood plasma. Overall, the level of duodenal iron 
absorption decreases as the total body iron levels increase, but an increase in red blood cell 
production or hypoxic conditions leads to an increase in iron uptake (Cairo, 2006). 
Within mammals, all cells need to take in the iron absorbed from the gut in order to 
perform metabolic functions. The iron of the body is often found in the blood plasma, 
transported by a protein called transferrin. Transferrin (Tf) has two binding sites for iron (Baker 
2003), and this diferric transferrin is taken into cells via Tf receptors expressed to varying 
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degrees on the surface of every cell (De Silva 1996). In times of higher metabolic need, Tf 
receptor gene expression can be increased to allow for higher iron uptake into the cell. Receptor 
– mediated endocytosis engulfs Tf, which releases its iron at the acidic pH of the endosome 
(Cheng 2004, Dautry-Varsat 1983, Dhungana 2004, Giannetti 2003, Klausner 1983). The iron is 
transferred to the cytosol by DMT1 and the apo-transferrin is returned to the cell surface for 
release into the blood plasma to bind and transport more iron.  
Yet another great source of iron uptake in host cells is the phagocytosis of senescent red 
blood cells. Erythrophagocytosis involves the engulfment of a damaged red blood cell into the 
phagosomal compartment of a macrophage.  Trafficking of the red blood cell follows 
phagolysosomal fusion resulting in acidification of the vacuole and breakdown of hemoglobin 
into heme molecules (Taketani 2005). Importantly, Nramp1, a divalent metal transporter 
expressed within phagolysosomal membranes, is required for the efficient recycling of heme in 
these macrophages. Without Nramp1, iron accumulates within the liver and spleen of mice (Soe-
Lin 2009). Through an unknown mechanism the heme is trafficked to the endoplasmic reticulum 
where its iron center is liberated via a eukaryotic heme oxygenase (HO-1) and the iron gets 
recycled for use in the body. Heme oxygenases are required for this iron recycling, and provide a 
substantial amount of iron back to the body.  
Heme oxygenase enzymes catalyze the oxidation of the tetrapyrolle ring of heme in order 
to break it open, releasing the iron and producing carbon monoxide (CO) and biliverdin in the 
process (Maines 1988). All three of these products of heme oxygenase activity have been 
implicated in host cellular protection during infection (Chung 2009). Specifically, initial 
pathogen – host interactions stimulate a host inflammatory response, where activated white 
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blood cells secrete cytokines, chemokines, antimicrobial molecules, and free radicals in order to 
aggressively fight the infection (Silva 2005). However, to avoid tissue injury from a continued 
inflammatory response, anti-inflammatory signals must be released to resolve the inflammation. 
Heme oxygenase-1 is thought to be responsible for this anti-inflammatory signaling, at least in 
part. For example, CO has been shown to reduce the inflammatory response through signaling 
through the p38 MAPK pathway (Otterbein 2000). Further, biliverdin and its downstream 
product bilirubin are both reducing agents, and are therefore considered antioxidants (Zhu 2011). 
They can reduce transcription of genes encoding iNOS and inflammatory cytokines, thus 
lowering the overall inflammatory response. Iron itself is a signal for the increased expression of 
ferritin, which protects the cell against oxidative damage (Balla 1992). 
About 20% of the iron in the human body is stored iron, and this iron can be found 
mostly in the parenchymal liver cells and reticuloendothelial macrophages. These macrophages 
are particularly noteworthy to this discussion because they are found in the spleen, liver, and 
bone marrow and function to recycle senescent red blood cells. The iron released from heme 
acquired via erythrophagocytosis is first destined to be stored in ferritin, like all excess iron of 
the cell. Ferritin is a cytosolic molecule that can multimerize into a “nanocage” capable of 
binding and storing up to 4500 iron atoms (De Domenico, 2006). As the amount of iron in the 
cell increases, a larger percentage is deposited in hemosiderin, an insoluble, aggregated form of 
partially digested ferritin. The highest concentrations of hemosiderin in the body are found in the 
reticuloendothelial macrophages (Bothwell, 1979). Cells can remove iron from ferritin for heme 
synthesis and for export through ferroportin, and ferroportin expression levels decrease in 
response to hepcidin (discussed later) (Nemeth 2004). Together, it can be surmised that copious 
amounts of iron and heme are constantly trafficking through these macrophages. There are still 
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many areas of heme trafficking within the cell to be elucidated (Hamza 2006), and there appear 
to be other, as yet unknown, ways for macrophages to take in iron (Chen 2005). 
 
Host iron sources during infection 
A universal feature of host infection is the disturbance of normal iron homeostasis (Brock 
1999). The host has adapted several mechanisms of iron deprivation in an attempt to starve 
pathogens of this necessary nutrient, the simplest being a decrease in DMT1 iron uptake in the 
intestinal lumen in response to hepcidin (Mena 2008). Hepcidin, a signal produced by the liver 
during inflammation, causes a systemic hypoferremia intended to resist microbial infection by 
decreasing the amount of extracellular iron available to the microbe (see Figure 1.1) (Roeser 
1980). This hypoferremic response acts to posttranslationally regulate ferroportin expression. 
Hepcidin can bind directly to ferroportin, causing the iron exporter to be taken into the cell, 
which decreases the amount of cellular iron exported (Nemeth 2004). In the host serum, iron is 
tightly bound to proteins such as transferrin with a high affinity in order inhibit its availability, 
and during the hypoferremic response, inflammatory signals cause the upregulation of hepcidin, 
which increases the cell surface expression of Tf receptors (Ganz 2011). This response causes 
the temporary uptake of serum iron into cells, where it is stored as ferritin.  
However, IFN-γ activation of the host macrophage by cells of the acquired immune 
response causes transferrin receptors on the surface of pathogen-infected cells to be 
downregulated, and also causes Nramp1 to be integrated into the phagosomal compartments 
(Wyllie 2002).  It is postulated that Nramp1 can then function to efflux iron from the 
phagosomal compartment, creating an extremely low iron environment for the pathogen. Further, 
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this IFN-γ activation of infected cells serves to increase expression of ferroportin, causing 
intracellular iron to be transported out of the cell (Nairz 2010). 
 
Pathogenic bacteria acquire iron from the host 
Acquisition of ferric and ferrous iron from the host 
Iron is an essential nutrient for most pathogenic microorganisms and plays a vital role in 
microbial pathogenesis. To survive within the iron-limited environment of the host, bacteria 
utilize iron-siderophore complexes, iron-binding proteins (transferrin, lactoferrin), free heme and 
heme bound to hemoproteins (hemoglobin, haptoglobin, hemopexin) as iron sources.  
In aerobic environments where ferric iron is dominant, it is often necessary to chelate the 
iron using siderophores (Andrews 2003). Siderophores are molecules with a high affinity for 
ferric iron, and under iron-limitation, most bacteria produce and excrete siderophores into the 
host environment. Once bound to iron, these ferri-siderophore complexes are transported back 
into the cell using specific receptors that are energized by the TonB/ExbB/ExbD system. B. 
abortus produces two siderophores, 2, 3-DHBA and brucebactin (González-Carreró 2002). 
Brucebactin is constructed from 2, 3-DHBA because mutation of the genes involved in 2, 3-
DHBA biosynthesis also results in loss of brucebactin production (González-Carreró 2002). The 
first gene in the 2, 3-DHBA operon encodes an isochorismate synthase, and mutating this gene 
(dhbC) results in a loss of all siderophore production. The role of siderophore production by B. 
abortus during infection of a pregnant cow is very significant, and a dhbC mutation results in 
loss of virulence within this acute model of infection (Bellaire 2003). However, 2,3-DHBA and 
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brucebactin are not required for the survival and replication of B. abortus 2308 in the mouse 
model of chronic Brucella infection suggesting that there must be an alternative source of iron 
within the macrophage of the host (Bellaire 1999).   
Still, the brucellae within the BCV must be able to overcome the Nramp1 – associated 
nutrient deprivation of divalent cations such as iron (Moreno 2002) and although the iron 
requirements for Brucella are extremely low by bacterial standards, obtaining such small 
amounts of needed iron can be challenging (Waring 1953). In addition to ferric acquisition by 
siderophore, there are several identified high affinity ferric iron ABC transporters. For example, 
SfuABC makes up a high affinity ferric iron transport system in Serratia marcescens that 
transports Fe
3+
 through the inner membrane of the cell (Angerer 1992). Brucella contains two 
operons with high homology to this sfu gene cluster, and these putative Brucella iron transporters 
have yet to be characterized to determine their role during infection (Roop 2011). 
Host-associated bacteria such as Brucella and E. coli O157:H7 are often exposed to 
ferrous iron either within the acidified compartment of the host cell environment (Brucella) or in 
an anaerobic environment (E. coli K12), and therefore have adapted methods to take in these 
forms of iron (Halaas 2010). The most well-characterized ferrous iron transporter was first found 
in E. coli K12, and is known as the Feo system (Hantke 1987). Extracellular Fe
2+
 is presumed to 
diffuse into the periplasm via undefined porins. It is then transported across the cytoplasmic 
membrane into the cytoplasm by FeoB through an apparent ATP/GTP-driven active transport 
process.   
In an aerobic organism and because of the soluble nature of ferrous iron, a ferroxidase 
enzyme may convert Fe
2+
 to the less reactive Fe
3+
 form in the periplasm, and there is a conserved 
ferroxidase enzyme encoded on the Brucella genome near the putative ferrous transport genes. 
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While there are no Brucella homologs to feoAB, a more recently described efeUOB operon in E. 
coli 0157:H7 (Grosse 2006) bears homology to an operon in Brucella (recently named bfe). The 
ferrous transport system of Brucella is currently being investigated to confirm its function and 
evaluate its contribution to virulence, but initial studies of these genes in the mouse model of 
chronic infection suggests that they are highly correlated to Brucella virulence and that ferrous 
iron is a relevant source of iron during infection.  
 
Acquisition of heme iron from the host 
 While both pathogenic and nonpathogenic bacteria have the ability to utilize heme as an 
iron source, in pathogenic bacteria this requirement for heme is often linked to virulence of the 
organism. In fact, in Staphylococcus aureus, heme is the preferred iron source over transferrin in 
vitro (Skaar 2004). Because extracellular heme in the host is found complexed with 
hemoproteins such as hemoglobin, extracellular pathogens in the host possess mechanisms for 
freeing the heme from these proteins, sometimes even directly from red blood cells. Hemolysins 
are exotoxins produced by bacteria like S. aureus that lyse red blood cells to release the 
hemoglobin (Kaplan 1963). Many bacterial outer membrane proteins can bind directly to 
hemoglobin before acting as proteases to remove the heme and transport it into the cell (Barton 
2005). Still other bacteria produce hemophores, which are siderophore – like small molecules 
with a high affinity for heme (Cescau 2007). Like siderophores, hemophores require active 
transport and the genes encoding them are tightly regulated. 
 Intracellular pathogens within the host are faced with a different type of host iron 
availability. A major function of the host macrophage is the recycling of senescent red blood 
cells (RBCs) (Crichton 2002). These RBCs are phagocytosed and their components, such as 
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heme, are transported to the ER where the eukaryotic heme oxygenase (HO-1) degrades the 
heme in order to utilize its iron center (Taketani 2005). Many bacterial pathogens have adapted 
to live within host cells, including Shigella, Salmonella, Mycobacterium, and Yersinia, and have 
adapted to utilize iron sources specific to their final location within the cell. For instance, due to 
the interactions of the brucellae-containing vacuole with the ER, heme may represent a relevant 
iron source for the brucellae during chronic infection (Roop 2004). 
Heme transport systems are present in both Gram positive and Gram negative bacteria. In 
Gram positive bacteria, the major challenge is overcoming the effects of the redox reactive heme 
molecule passing through the extensive peptidoglycan cell wall. As a result, there are several cell 
wall – anchored proteins that function to pass the heme molecule through the peptidoglycan 
layer. Heme transporters have been confirmed in Streptococcus pyogenes (Lei 2003), Listeria 
monocytogenes (Jin 2006), Corynebacterium diphtheriae (Allen 2011), and the most thoroughly 
studied, Staphylococcus aureus (Torres 2006). In S. aureus, IsdB and IsdH acquire heme from 
hemoglobin and other hemeproteins and pass it through to IsdA and IsdC. These proteins transfer 
the heme moiety to a transmembrane ABC transporter, IsdDEF, and IsdG and IsdI degrade the 
heme for its iron once it has entered the cell (Mazmania n 2003). The genes of these Gram 
positive bacterial heme uptake systems are, in all known cases, regulated by iron and heme either 
through ChrAS, DtxR, Fur, or some combination of these with other unknown regulators. While 
the heme transport system in S. aureus has been shown to contribute slightly to absess formation, 
mutation of components of the heme acquisition system in L. monocytogenes reduces virulence 
of the organism by over 50 fold (Torres 2006, Jin 2006). Together, these data support the 
hypothesis that the ability to derive iron from heme can contribute to survival of some bacteria in 
vivo.  
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Heme, a tetrapyrolle ring with iron as its center, is taken into Gram negative bacteria 
using a highly conserved method of transport. Bacterial pathogens including Shigella dysenteriae 
(Burkhard 2008), Pseudomonas aeruginosa (Ochsner 2000), Escherichia coli (Torres 1997), 
Vibrio cholerae (Mey 2001), Yersinia pestis (Thompson 1999), Haemophilus influenzae (Seale 
2006), Bradyrhizobium japonicum (Nienaber 2001), and the Bordetella spp. (Murphy 2002) 
produce heme transporters and have the capacity to use heme as an iron source. In Gram 
negative bacteria, this transport involves the binding of a heme molecule to a TonB – dependent 
outer membrane spanning protein, where energy from the proton motive force shuttled from the 
inner membrane via a TonB, ExbB/D protein complex is used to transport the heme molecule 
into the periplasm. A periplasmic binding protein that is specific for heme binds to the molecule 
and the protein-heme complex then binds to an inner membrane permease, where ATP from an 
associated ATPase is hydrolyzed to provide energy to bring the heme molecule into the bacterial 
cell (see Tong 2009 for review). Once in the cytoplasm, the heme is either broken down for its 
iron center by a heme oxygenase or used directly as a cofactor. 
A well-characterized heme transport system is that of Shigella dysenteriae (see Figure 
1.3). The outer membrane transporter, ShuA, has conserved structural motifs consistent with 
TonB-dependent transport (a TonB box – Asp- Thr- Leu- Val- Val- Thr- Ala- Asn) (Köck 1987) 
as well as two critical histidine residues, His119 and His448, that are necessary for heme binding 
(Bracken 1999). ShuT is a monomeric protein having a molecular mass of 28.5 kDa following 
proteolytic processing of the periplasmic signaling peptide. ShuT binds one heme per monomer 
with high affinity (Eakanunkul 2005). The high-affinity PBPs are critical in maintaining the 
selectivity and specificity of transport. Not only do the PBPs determine specificity, but they also 
play an integral part in the transport process by complexing to the ATP-Binding Cassette (ABC) 
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proteins (U and V) to trigger release of their substrate. The release of substrate from the PBP to 
the ABC transporter is thought to be coupled to the conformational changes in the periplasmic 
protein (Eakanunkul 2005).  
Translocation of heme into the cytoplasm is facilitated by a heme-specific ABC 
transporter, ShuUV. The heme ABC transporter consists of two membrane-spanning domains 
(MSDs) of ShuU, which form a translocation pathway, and two nucleotide-binding domains 
(NBDs) of ShuV. Interaction of the PBP with the transporter triggers the closing of the NBD 
interface, generating the open conformation of the PBP such that the affinity for the ligand is 
reduced. This conformational change in ShuUV opens the translocation channel and brings the 
NBDs together. Following ATP hydrolysis, the PBP is released, and the NBD dimer reopens, 
releasing the substrate and resetting the transporter (Burkhard 2008). In several bacteria, the 
release of the heme into the cytoplasm of the cell also requires binding of a shuttle protein ShuS, 
which transports the heme to a heme degrading enzyme.  
A second type of heme transport involves the use of hemophores, which function much 
like siderophores to bind with high affinity to heme molecules in the environment and then be 
transported back into the cell. Several Gram negative bacteria produce hemophores, including 
Haemophilus influenzae, Serratia marcescens, Pseudomonas aeruginosa, Pseudomonas 
fluorescens, Yersinia pestis and Yersinia enterocolitica (Wandersman 2004). Although the 
essential design for the ABC transporters is similar, more and more exceptions are being 
discovered. For example, the heme-binding protein HmuT of Yersinia pestis actually binds two 
heme molecules instead of the typical one (Mattle 2010). Also, in Escherichia coli K-12, which 
does not contain a genuine heme transport system, heme is transported by the Dpp peptide ABC 
transporter (Letoffé 2006). Another E. coli protein, NikA, binds heme in the periplasm and can 
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function in heme transport even though it also functions to bind nickel (Shepherd 2007). In 
Sinorhizobium meliloti and Pseudomonas aeruginosa, heme and the siderophore can share the 
proteins of an ABC transporter (Cuív 2008, Rossi 2001).  
In most cases, both the heme and siderophore uptake systems are Fur regulated. Notably, 
Shigella dysenteriae heme transport regulation includes both Fur and a sRNA RhyB, and in the 
alpha proteobacteria, where Fur actually functions as a Mur, the heme transport machinery is 
regulated by both RirA and Irr.  In many cases, the contribution of heme transport to virulence is 
unknown or insignificant, however heme uptake is required for virulence in Haemophilus 
influenzae (Morton 2007), enterohaemorrhagic E. coli (Torres 1997), and Bordetella pertussis 
(Brickman 2007). 
Once inside the cell, the heme molecule must be broken down for iron utilization or 
storage. One or more heme oxygenase enzyme(s) is responsible for the degradation, and 
functions to release iron from its tetrapyrolle ring through a series of oxidative steps (Maines 
1988). The reaction requires a total of three oxygen molecules and seven electrons for the 
cleavage of one heme molecule to release the iron atom (Montellano 2000). The HmuO heme 
oxygenase protein from Corynebacterium ulcerans was the first bacterial heme oxygenase to be 
identified, and has many similarities to the eukaryotic HO-1 heme oxygenase (Schmitt 1997). 
Other heme oxygenases were quick to be identified based on their homology to HmuO of C. 
ulcerans, including those of Pseudomonas aeruginosa and Neisseria meningitidis (Ratliff 2001 
and Zhu 2000). More recently, novel heme oxygenases have been identified in pairs of two in 
both Staphylococcus aureus and Bradyrhizobium japonicum (Skaar 2004b and Puri 2006). In 
fact, a heme oxygenase from Brucella, BhuO, was identified based on its high amino acid 
homology to those from B. japonicum. Bacterial heme oxygenases are a hot topic in research 
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these days, and Wilkes et al have identified chemical heme oxygenase inhibitors with the intent 
to find better drug targets (Furci 2007). 
It is worth noting, however, that although the main mechanism of heme uptake in these 
bacteria appears to be quite similar, there are often other genes of unknown function encoded 
within the same locus and shown to be required for utilization of heme as an iron source. Some 
are thought to function as heme shuttles, transporting the heme to the heme oxygenase within the 
cytoplasm, such as ShuS of Shigella (Burkhard 2008). Other proteins encoded within these heme 
uptake loci are still “hypothetical” or else denoted with letters from the end of the alphabet to 
follow the T, U, and V annotations of the cytoplasmic membrane transporter, and although often 
required for utilization of heme as an iron source such as HugWXZ, their exact function has yet 
to be elucidated (Henderson 2001). 
B. abortus 2308 has been shown to utilize heme as an iron source in vitro (Paulley 2007), 
and in keeping with heme transport in other bacteria, B. abortus uses a specific outer membrane 
receptor (BhuA) as well as a cytoplasmic membrane – spanning heme transport complex. The B. 
abortus heme uptake proteins have high amino acid similarity with that of the well-characterized 
Shigella dysenteriae heme uptake system. A B. abortus bhuA mutant strain grows poorly in low 
iron media unless exogenous iron, such as FeCl3, is added to the cells. This mutant strain cannot 
utilize heme as an iron source in vitro (Paulley 2007). Also, BhuA is required to maintain a 
chronic spleen infection in experimentally infected BALB/c mice, indicating a role for brucellae 
iron acquisition from heme in vivo (see Figure 1.4). While the regulation of bhuA is still being 
elucidated, recent work shows that transcription of bhuA requires the iron responsive regulator 
Irr (Anderson 2011). 
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Figure 1.1 Host iron sources during infection. Bacterial infection of the host causes an 
increase in the production of hepcidin by the liver, which downregulates expression of DMT1, 
resulting in less intestinal lumen iron uptake. Hepcidin also starves extracellular bacteria for iron 
by increasing cellular transferrin (Tf) receptors and by causing ferroportin to be taken into the 
cell, both which result in decreased serum iron levels and increased intracellular ferritin iron 
storage. Alternately, intracellular bacteria stimulate IFN-γ production, which causes a decrease in 
Tf receptors on pathogen-infected cells as well as an increase in phagosomal expression of 
NRAMP1. IFN-γ also causes the increased expression of ferroportin on the cell surface, causing 
more iron to be pumped out of the cell. The result of IFN-γ is a decrease in overall cellular and 
phagosomal iron within infected cells. 
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Figure 1.2 RirA and Irr regulate several iron acquisition genes. RirA senses iron through its 
FeS center, and under high iron cellular conditions it binds to its cognate IRO box motifs, 
repressing the expression of several iron acquisition genes. In contrast, Irr protein binds to its 
cognate ICE box motifs under low cellular iron conditions, and Irr is degraded under high iron 
conditions. Abbreviations of bacterial species: Bradyrhizobium japonicum (B.j.), Rhizobium 
leguminosarum (R.l.), Brucella abortus (B.a.), and Sinorhizobium meliloti (S.m.). 
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Figure 1.3. Shigella heme transport model. Heme uptake in Gram negative bacteria is highly 
conserved and has been very well-characterized in Shigella. Transport of heme through the outer 
membrane is carried out by ShuA, a TonB/ExbB/ExbD – energized transporter. Heme is bound 
by ShuT in the periplasm and shuttled to ShuUV, a cytoplasmic permease energized by an 
ATPase. Once in the cytoplasm, the heme is shuttled to a heme oxygenase (HO) where it is 
broken down into iron, carbon monoxide, and biliverdin. 
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Figure 1.4 BhuA contributes to the virulence of B. abortus. Previous work with BhuA, the 
outer membrane heme transport protein of B. abortus 2308, has demonstrated a link between B. 
abortus heme utilization and its virulence within the mouse model. By the fourth week of 
Brucella infection within the Balb/c mouse, the bhuA mutant is significantly attenuated 
compared to B. abortus 2308 (Paulley 2007). 
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Statement of the problem 
Brucella abortus is a stealthy pathogen that lacks the classical virulence factors of other 
known pathogens. Instead, the pathogenesis of this organism depends solely on its ability to 
invade and replicate within the phagocytic cell of the host. The brucellae invade the macrophage 
into phagosomal compartments known as Brucella – containing vacuoles (BCV). The BCV 
acquires Nramp1, a transporter that pumps divalent cations such as iron out of this phagosome. 
Therefore, the ability to acquire iron in this niche is critical to Brucella survival.  
Although iron is limited in the BCV, the macrophage recycles red blood cells, 
transporting heme to the eukaryotic heme oxygenase located in the endoplasmic reticulum (ER) 
of the cell. During its altered trafficking, the BCV fuses with the ER. The ER is the replicative 
niche for the brucellae, suggesting a sudden increase in the availability of nutrients. It is likely 
that the brucellae acquire their iron through the transport of heme in this environment. In fact, the 
ability to transport heme through the Brucella outer membrane heme transporter, BhuA 
(Brucella heme utilization), has been directly tied to the virulence of B. abortus.  Because heme 
transport is necessary for the survival of Brucella in the mouse model of infection, it is important 
to identify and characterize the entire heme transport machinery. Typically, these components 
would be encoded together on the chromosome, but in Brucella’s genome there were no genes 
located near bhuA that contained the conserved motifs often associated with heme transport. 
NCBI BLAST searches using the well-characterized Shigella heme transporter amino acid 
sequences led to the identification of possible cytoplasmic membrane heme transport 
components in Brucella abortus (BAB2_0483-0485). The research described in this dissertation 
aims to evaluate the role of these proteins, BhuT, BhuU, and BhuV, (BhuTUV) in heme 
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transport by B. abortus 2308 with the intent to determine the contribution of these proteins to the 
ability of B. abortus to maintain infection in the mouse model.  
Virulence of Brucella is dependent on the ability to obtain heme from its environment, 
but the brucellae must also be able to utilize this heme as an iron source. Freeing the iron from 
heme usually requires the presence of one or more heme oxygenases, and one has been identified 
in Brucella based on its high homology to HmuD in Bradyrhizobium japonicum as well as its 
ability to remove iron from heme in a reaction typical to heme oxygenases. The overall 
contribution of this heme oxygenase, renamed BhuO, to the ability of Brucella abortus 2308 to 
acquire iron from heme is also assessed in this dissertation.  
Additionally, the separation of these heme uptake and utilization genes on the 
chromosome is unique to Brucella and raises the possibility of differential regulation of these 
genes. The environmental stimuli often associated with heme uptake gene regulation involve 
both heme- and iron- responsive mechanisms. In the other alpha proteobacteria, the RirA 
(rhizobial iron regulator) and Irr (iron responsive regulator) proteins work together to carry out 
this regulation. The research presented here aims to identify the roles of the iron – responsive 
regulators, RirA and Irr, in the expression of bhuTUV and bhuO under physiologically relevant 
conditions in Brucella abortus 2308. 
 The outer membrane heme transporter mutant, bhuA, establishes but cannot maintain 
infection within the host model, making it attractive as a vaccine candidate since live, attenuated 
vaccines are believed to be the most effective for prevention of brucellosis. Also, bacterial heme 
oxygenases are very different from mammalian heme oxygenases, and researchers are 
investigating them as potential drug targets.  Improving our knowledge of the heme utilization 
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machinery in Brucella may one day be used by others to develop better vaccines and alternatives 
to the current intensive antibiotic regimen that is used to treat brucellosis in humans. 
Chapter 2: BhuTUV is required for heme utilization in Brucella 
abortus 2308 
Abstract 
 Brucella abortus is a Gram negative bacterium belonging to the alpha proteobacteria 
class. B. abortus resides in the phagosomal compartment of the host macrophage where essential 
nutrients such as iron are limited. Most bacteria need iron, and within this macrophage niche, 
heme is a likely source of iron due to the breakdown of red blood cells by the host macrophage. 
Heme transporters in Gram negative bacteria are highly conserved, and include components for 
outer membrane, periplasmic, and cytoplasmic membrane transport. While BhuA has been 
characterized as the outer membrane heme transporter of B. abortus, the periplasmic and 
cytoplasmic components have only recently been identified. NCBI BLAST searches using the 
well-characterized Shigella heme transporter amino acid sequences led to the identification of 
possible cytoplasmic membrane heme transport components in Brucella abortus (BAB2_0483-
0485). Here we provide experimental evidence that these gene products, BhuT, BhuU, and BhuV 
(BhuTUV) are the missing components for heme transport and that they are required in order for 
B. abortus to use heme as an iron source. The bhuTUV locus is regulated in both an iron- and 
growth phase- dependent manner, and transcription of these genes is repressed by both Irr and 
RirA, the primary iron-responsive regulators in the alpha proteobacteria. 
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Introduction 
Brucella abortus is a Gram-negative bacterium that causes the zoonotic infection 
brucellosis in humans. Brucellosis is a flu-like illness that can be treated with a combination of 
doxycycline and rifampin for 6 weeks, however, relapses may occur and symptoms can continue 
for years (Ariza 2007). B. abortus is an intracellular pathogen, and primarily resides within the 
phagosomal compartments of host macrophages. An infected macrophage will rid itself of 
intracellular iron stores in order to deprive the pathogen of iron, and in the phagosomal 
compartment the brucellae must overcome this iron deprivation in order to survive (Cellier 2007, 
Byrd 1989, Nairz 2010). In vitro, B. abortus can utilize the iron sources 2,3-dihydroxybenzoic 
acid (siderophore), heme, and FeCl3 (Bellaire 2003, Paulley 2007). A strain that lacks the ability 
to produce siderophore shows no growth defect in the mouse model of chronic infection, 
suggesting that iron uptake via siderophore is not the main source of iron within the macrophage. 
Since macrophages recycle aged red blood cells, a physiologically relevant source of iron for the 
brucellae within this niche is heme. 
Many bacterial pathogens rely on heme for their iron, and the basic components of heme 
transport are highly conserved in Gram negative organisms. This iron transport includes TonB-
dependent heme transport through the outer membrane and a periplasmic binding protein to 
shuttle heme to an ATP-dependent cytoplasmic membrane transporter (Siudeja 2005). Once the 
heme enters the cytoplasm of the cell, it is degraded for its iron component by one or more heme 
oxygenase(s) (Frankenberg-Dinkel 2004).  
In B. abortus, the outer membrane heme transporter BhuA (Brucella heme uptake) has 
been characterized and is required for virulence in the mouse model of infection (Paulley 2007). 
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Because of this contribution of heme uptake to B. abortus virulence, it was imperative that we 
identify the rest of the heme transport machinery. The heme transport components of Gram 
negative bacteria typically share a genetic locus; however, in B. abortus there are no likely 
candidates for the genes that encode cytoplasmic heme transport components near bhuA. 
However, searches of the Brucella genome identified the locus BAB2_0483-0485 based on its 
high homology to the genes encoding cytoplasmic components of Shigella heme uptake 
machinery (shuTUV). Here we constructed an isogenic mutant in the locus encoding these gene 
products, BhuT, BhuU, and BhuV (BhuTUV) in order to determine its role in heme uptake. 
Excess iron in the cell can react with oxygen, in a reaction commonly referred to as 
Fenton chemistry, creating toxic oxygen radicals that are very damaging to DNA and other 
cellular components. Due to the highly toxic nature of excess iron in the cell, iron uptake is 
regulated in an iron-responsive manner. In most bacteria, Fur is the iron-responsive regulator 
responsible for repressing the heme uptake genes in the presence of iron (Andrews 2003). 
However, most of the alpha proteobacteria lack Fur, and instead utilize two major regulators, Irr 
and RirA, in order to moderate iron uptake in the cell. For instance, in Agrobacterium 
tumefaciens RirA (rhizobial iron regulator) is an Fe-S protein that represses iron uptake genes 
such as those encoding siderophore and heme uptake under iron replete conditions (Ngok-Ngam 
2009). Irr (iron responsive regulator) performs a similar function in the alphas, but can act as 
either a repressor or an activator, and is required for bhuA expression in B. abortus (Anderson 
2011). Irr and RirA have been shown in the alphas to have interlinking roles that serve to control 
intracellular iron levels (Hibbing 2011). These interlinking roles are possible because Irr is only 
present in low iron conditions and RirA is only functional in high iron conditions (Hibbing 
2011). This allows the cell to regulate iron under all conditions in a finite manner using both 
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regulators. Therefore, we sought to define the roles of these two regulators in controlling the 
expression of the heme uptake genes bhuTUV in B. abortus 2308. 
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Materials and Methods 
Bacterial strains, media, and growth conditions. Brucella abortus strains (Table 2.1) were 
routinely grown in brucella broth at 37C with aeration, or on Schaedler agar supplemented with 
5% bovine blood (SBA) at 37C under 5% CO2. Kanamycin (45 g/ml) and/or ampicillin (25 
g/ml) were added to these media as appropriate for the selection of strains with antibiotic 
resistance markers. Escherichia coli strain DH5 was used for the propagation of plasmids for 
procedures involving recombinant DNA, and this strain was cultivated at 37C in LB broth or on 
LB agar plates containing either 100 g/ml ampicillin (Sigma), or 45 g/ml kanamycin (Sigma) 
when appropriate. 
  
Construction of a B. abortus bhuTUV mutant. 
  Polymerase chain reaction (PCR) utilizing Taq polymerase (Invitrogen) with the 
oligonucleotide primers bhuTUV-1F and bhuTUV-1R (Table 2.2) was used to amplify a 4309 bp 
fragment encompassing the bhuTUV genes (BAB2_0483-0485) from B. abortus 2308 genomic 
DNA. This fragment was then cloned into pGEM
®
-T Easy (Promega).  The resulting vector, 
pGEMbhuTUV, was digested with MscI to remove 705 bp from the 3’ end of bhuT and most of 
bhuU. This fragment was ligated with a 1345 bp fragment containing the aph3a gene from pKS-
Kn (Kovach, 1995). The resulting construct, pGEMΔbhuTUV, was introduced into B. abortus 
strain 2308 by electroporation and transformants were selected on SBA supplemented with 45 
µg/ml kanamycin. Putative B. abortus bhuTUV deletion mutants were identified based on their 
resistance to kanamycin and sensitivity to ampicillin, and their genotypes confirmed by PCR 
analysis and DNA sequence analysis. Chromosomal DNA preparations from putative deletion 
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mutants and strain 2308 were prepared and oligonucleotides bhuTUV-1F and Kan R (Table 2.2) 
were used to determine the presence of the aph3a-based gene in the proper orientation, the 
absence of the ampicillin resistance gene from pGEM
®
-T Easy (Promega) (amp F and amp R), 
and the absence of the 705 bp in the middle of the operon (bhuTUV -2F and bhuTUV -2R). One 
confirmed B. abortus bhuTUV mutant was selected for further phenotypic evaluation and given 
the designation JFO2.  
  
Reconstruction of the bhuTUV locus in B. abortus JFO2.  
 Reconstruction of the mutated bhuTUV genes in JFO2 was chosen as a strategy for verifying 
the link between genotype and the phenotype exhibited by this strain, rather than genetic 
complementation with a plasmid-borne bhuTUV operon. A 4309 bp fragment encompassing the 
bhuTUV operon from B. abortus strain 2308 genomic DNA was amplified using the primers 
bhuTUV-1F and bhuTUV-1R (Table 2.2) and cloned into pNPTS138Ap (Table 2.1), an 
ampicillin–resistant derivative of the sacB-containing ColE1-based pNPTS138 (Spratt, 1986). 
The resulting plasmid, designated pNPTS138bhuTUV was introduced into B. abortus JFO2 by 
electroporation, and a previously described sacB-based counterselection strategy (Bellaire et al., 
2003) was used to select for derivatives of these mutants in which the mutated bhuTUV genes 
had been replaced by the parental bhuTUV genes. The genotype of the resulting B. abortus strain, 
designated JFO1RC was confirmed by PCR amplification and sequence analysis. 
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Construction and genetic complementation of a B. abortus rirA mutant.   
A 757 bp region encompassing the rirA gene (BAB2_0678) was amplified from B. 
abortus 2308 genomic DNA by PCR (rirAF: 5’-CCGGCAGATCGCAGTAAATT-3’, rirAR: 5’-
CGCCGACTGTGTTACCTCAA-3’) and cloned into pGEM®-T Easy (Promega) (Anderson 
2006).  The resulting plasmid (pEA19) was digested with SmaI/AscI releasing a 303 bp fragment 
internal to the rirA coding region. This linearized plasmid was then treated with the Klenow 
fragment of DNA polymerase I and ligated to a 987 bp SmaI/HincII fragment containing the 
chloramphenicol acetyltransferase (cat) gene from pBlueCM2 (Robertson 2000). This plasmid 
(pEA20) was used to construct a rirA mutant (designated BEA4) in B. abortus 2308 via gene 
replacement using previously described procedures (Elzer 1994).  The genotype of the B. abortus 
BEA4 was confirmed by PCR analysis of BEA5 chromosomal DNA with rirA-, cat- and 
pGEM
®
-T Easy- specific primers.  
 A 775 bp fragment containing the rirA open reading frame was excised from pEA19 by 
EcoRI digestion and ligated into EcoRI-digested pMR10 (Gee 2005) to produce pEA21. The 
rirA containing EcoRI fragment was also inserted into pBBR1MCS4 (Kovach 1995) to produce 
pEA30. These plasmids were introduced independently into B. abortus BEA4 by electroporation 
(Elzer 1994).  
Determination of the growth characteristics of B. abortus strains in iron limited culture 
media. 
 B. abortus strains were grown on SBA plates at 37°C with 5% CO2 for 48 h and harvested 
into PBS. The resulting cell suspensions were used to inoculate 25 ml low iron minimal medium 
with the addition of 10 M ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid) (EDDHA) in 
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125 ml Erlenmeyer flasks at a final concentration of approximately 10
6
 CFU/ml. When 
applicable, the medium was supplemented with either 50 M FeCl3, 25 M deferrated hemin 
(see below), or 25 M deferrated hemoglobin (hemoglobin was deferrated by adding 20 M 
desferoxamine, a siderophore that cannot be utilized by Brucella). Cultures were incubated at 
37°C with shaking at 165 rpm, and at 24 hour time points post inoculation these cultures were 
serially diluted in PBS and plated on SBA, followed by incubation at 37°C under 5% CO2. 
Capacity of the B. abortus strains to use heme as an iron source in vitro.  
Free iron was removed from the hemin stock solutions used for the iron source utilization 
assays using the procedure described by Staggs and Perry (Staggs 1991). To test for the capacity 
of hemin to serve as an iron source, B. abortus strains were grown on SBA for 48 h at 37°C with 
5% CO2. Bacterial cells were harvested into phosphate-buffered saline (pH 7.2), and the optical 
density at 600 nm was adjusted to 0.15 (corresponding to 10
9
 CFU/ml). One hundred-microliter 
portions of these bacterial cell suspensions were then added to 500-ml flasks containing 100 ml 
low-iron minimal medium, and the flasks were incubated at 37°C with shaking at 165 rpm. 
Following 96 h of growth the optical densities at 600 nm of the bacterial cultures were adjusted 
to 0.15, and 100 µl portions of the bacterial cell suspensions were mixed with 4 ml 0.7% Noble 
agar (Difco). The mixtures were overlaid onto TSA plates containing 125 µM EDDHA. Seven-
millimeter sterile filter paper (Whatman no. 3) disks were placed onto the plates, 30 µl of a 25 
mM solution of hemin, or 20 µl of a 50 mM solution of FeCl3 was added to the filter disks, and 
the plates were incubated for 96 h at 37°C with 5% CO2. Following this incubation period, the 
diameter (in millimeters) of the zone of bacterial growth around each filter disk was measured 
and recorded. 
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Relative quantification of bhuT transcript levels using real-time RT-PCR.  
Total cellular RNA was isolated from B. abortus 2308, BEA2 (2308 irr-) (Anderson 
2011) and BEA4 (2308 rirA-) following
 
growth in low-iron minimal medium and low-iron 
minimal medium
 
supplemented with 50 µM FeCl3  at 72 hours and 120 hours post inoculation 
using a previously described procedure (Caswell  2012). The RNA was treated with
 
RQ1 DNase 
(Ambion) following the manufacturer's instructions
 
to remove residual contaminating DNA. The 
absence of DNA from
 
the RNA preparations was confirmed via PCR analysis and lack of an 
amplified product as visualized on an agarose gel confirmed that the RNA sample was free of 
DNA contamination. Concentrations of RNA
 
in the samples were determined by measuring the 
absorbance at
 
260 nm using a NanoDrop ND-1000 Spectrophotometer.
 
 
The SuperScript III First-Strand Synthesis System for RT-PCR kit (Invitrogen) was used 
to convert 1 µg of RNA from these preparations into cDNA for each preparation
 
following the 
manufacturer's instructions and using the random
 
hexamers supplied with the kit. The cDNA 
preparations were then
 
used as the templates in real-time RT-PCR analysis along with FastStart 
SYBR Green Master 2X (Roche) to evaluate
 
the relative levels of gene-specific mRNA 
transcripts in the
 
total cellular RNA preparations. Gene-specific oligonucleotide
 
primers were 
utilized (see Table 2.2). The differences in the levels of the bhuT- specific transcripts present 
under each condition were calculated using methods described by Pfaffl (Pfaffl, 2001), using the 
16S gene as an internal standard. This gene encodes the ribosomal 16S protein, and its 
expression is constitutive in B. abortus 2308 under the experimental conditions used here.  
Statistical analysis. 
All statistical analysis was performed using the Student’s two-tailed t-test. P values of 
less than 0.05 were considered significant (Rosner, 2000).  
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Results and Discussion 
Efficient iron acquisition is critical for an invading microbe’s survival and virulence. The 
erythrophagocytosis by the macrophage provides a considerable heme flux throughout the cell 
(Crichton 2002), making heme a biologically relevant source of iron for the brucellae (Roop 
2011). B. abortus contains genes encoding several other iron acquisition pathways (Roop 2011), 
however, no other iron uptake system is able to obtain enough iron to compensate for the loss of 
the outer membrane heme transporter in B. abortus (Paulley 2007). Because heme uptake is 
linked to the pathogenesis of Brucella abortus, it was essential for us to identify the rest of the 
heme acquisition machinery. In most cases, the genes encoding heme uptake components are 
located together in the same chromosomal region; therefore the logical candidates for encoding 
the rest of the heme transporter are directly downstream from bhuA (BAB2_1148-1149) (Figure 
2.1A). However, these genes, annotated as nagC and tauC, do not encode the conserved amino 
acid residues found to be required for cytoplasmic heme transport in Shigella, and real time PCR 
analysis of their transcripts (Figure 2.1C) showed a lack of iron-responsiveness that is usually 
observed with heme transporters. Further, a search of the Brucella abortus 2308 genome 
identified BAB2_0483-0485 as encoding much better candidates for cytoplasmic heme transport 
with high amino acid homology to ChuTUV of Escherichia coli as well as to the well-
characterized ShuTUV transporter in Shigella dysenteriae (Torres 1997, Wyckoff 1998). In 
Shigella, the Tyr-94 of the ShuT periplasmic binding protein has been shown to be necessary for 
heme binding and correlates to the Tyr-89 of BhuT in Brucella (Eakanunkul 2005) (Figure 
2.1D). ShuU contains two histidine residues required for binding of ShuT and subsequent release 
of the heme, and BhuU also contains these histidines (Burkhard 2008). BhuV includes the 
conserved features of an ATP – binding subunit. RT-PCR analysis using RNA from growth in 
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low iron conditions (Figure 2.1B) of this chromosomal region confirmed that bhuT, bhuU, and 
bhuV are all cotranscribed and since their open reading frames overlap each other by 4 base 
pairs, they are probably translationally coupled.  
In order to determine whether or not B. abortus BhuTUV transports heme, an isogenic 
mutant was constructed (JFO2) and subjected to low iron conditions in liquid and on solid media. 
Growth in low iron miminal medium showed a limited growth defect for JFO2 in late stationary 
phase (data not shown). However, the addition of the chelator ethylenediamine-N,N'-bis(2-
hydroxyphenylacetic acid) (EDDHA) to the low iron medium resulted in significant growth 
impairment of JFO2 compared to B. abortus (Figure 2.2A). This level of iron restriction is 
physiologically relevant because the brucellae require such low amounts of iron compared to 
most bacteria (Gerhardt 1950) as well as due to the severe iron restriction created by the host 
macrophage because of the active transport of iron out of the cell through ferroportin as well as 
the removal of divalent cations by Nramp1 from the phagosome where the brucellae resides 
(Cellier 2007, Byrd 1989, Nairz 2010). Importantly, growth of JFO2 can be restored with the 
addition of 50 µM FeCl3 (Figure2. 2B), but not with the addition of 50 µM heme (Figure2. 2C) 
as well as by genetic reconstruction of the locus (JFO2RC). These data demonstrate that the 
bhuTUV mutant strain (JFO2) is unable to use heme as an iron source. To further confirm that 
JFO2 has a defect in its ability to use heme as an iron source, its growth was compared to both 
the parental B. abortus 2308 strain and HR1703 (2308 bhuA-) on chelated TSA plates with 
varying iron sources provided on a paper disc centered in the plates (Table 2.3). Under these 
conditions, both HR1703 and JFO2 are unable to grow when heme is provided as the sole source 
of iron, but all strains are able to grow using FeCl3 as an iron source. These experimental 
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findings support the proposition that bhuTUV encodes the components that work in conjunction 
with BhuA for the transport of heme into B. abortus 2308.  
To our knowledge, this is the first formal report that Brucella can use hemoglobin as an 
iron source, and the physiologic relevance of this within the macrophage niche is as yet 
unknown. Also, because hemoglobin can be used as an iron source for B. abortus 2308 but not 
for the JFO2 heme uptake mutant (Figure 2.2D), there must be a protein responsible for removal 
of the heme from the hemoglobin. Perhaps, like Shigella, it is the outer membrane heme 
transport protein itself that is performing this function (Cobessi 2010).  
Due to the generation of toxic hydroxyl radicals through Fenton chemistry, iron and heme 
transport genes are typically regulated in an iron – responsive manner (Andrews 2003). Real 
time PCR analysis of the bhuT transcript under low iron conditions at 72 hours post inoculation 
(log phase) and 120 hours post inoculation (stationary phase) demonstrated both an iron-
responsive component as well as a growth phase-dependent component to the regulation of this 
operon (Figure 2.3). The two main iron responsive regulators found in alpha proteobacteria are 
Irr and RirA (Hibbing 2011). Irr was recently found to bind to the promoter region of bhuA, and 
is required for its iron - responsive expression (Anderson 2011). In order to assess the roles of Irr 
and RirA in the iron responsive regulation of bhuTUV, the bhuT transcript was examined in iron 
deplete and replete conditions in B. abortus 2308, BEA2 (2308 irr-), and BEA4 (2308 rirA-). In 
contrast to the positive effect of Irr on the expression of bhuA, Irr appears to repress bhuT 
expression during log phase growth; however it does not play an observable role later during 
stationary phase of growth. RirA appears to have an inverse relationship, having no observable 
effect on bhuT transcript during log phase growth, but clearly playing a repressive role on bhuT 
during stationary phase.  
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The gene that encodes BhuA, the outer membrane heme transporter, is highly upregulated 
in response to iron deprivation, but there is only a modest iron-responsive increase in expression 
of bhuT by comparison (Paulley 2007, Anderson 2011). While both regulators repress bhuT 
expression significantly in response to iron deprivation, there are no conserved binding motifs 
for these regulators such as the Irr  iron control element (ICE) found in Bradyrhizobium 
(Rudolph 2006) or the RirA iron-responsive operator (IRO) found in Rhizobium (Yeoman 2004) 
for them in the promoter region of bhuTUV and the authors believe that this may be an indirect 
regulatory relationship involving a third regulator that may exhibit both iron- and growth phase- 
responsive characteristics. In Bordetella avium, heme utilization is regulated by a heme-
responsive extracytoplasmic sigma function (ECF) called RhuI (Kirby 2001). RhuI belongs to a 
subfamily of σ-70 type proteins that are iron regulated (usually by the global iron regulator Fur) 
and turn on various iron acquisition genes as well as genes encoding adaptive proteins necessary 
for pathogenesis of the organism. Brucella encodes the ECF homologs RpoE1 and RpoE2 that 
should be examined for their potential role as this third regulator. Alternatively, ChrAS is a 
heme-sensing two component regulator found in C. diphtheria to activate transcription of both a 
heme export system and a heme oxygenase in the presence of heme (Schmitt 1999; Bibb 2010).  
We have some preliminary evidence that ChrA is activating bhuTUV and also bhuA, which 
would provide a feedback mechanism for the increased expression of bhuA, possibly allowing 
for full expression of the heme uptake machinery. 
These experimental findings conclusively show that BhuTUV is the cytoplasmic 
membrane heme transporter that works in conjunction with BhuA. The original bhuA mutant was 
constructed using a chloramphenicol resistance cassette. Recently the CDC instituted new 
guidelines for this select agent that no longer allows chloramphenicol resistance to be introduced 
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into the animal models, and therefore a new bhuA kanamycin resistant mutant is currently under 
construction with the intent to use it as a tool for comparison with the bhuTUV mutant in the 
mouse model of infection. Since BhuA was shown to be required for the maintenance of chronic 
infection in the Balb/c mouse model, it will be important to determine what role, if any, 
BhuTUV plays in the virulence of Brucella. 
To our knowledge, the separation of heme transport genes appears to be unique to 
Brucella, and this genetic organization is conserved in all of the published Brucella genomes. 
The fact that bhuA and bhuTUV show different patterns of iron-responsive regulation certainly 
suggest that there is an evolutionary benefit to having these in separate loci. This separation 
probably allows for fine-tuned regulation of the genes responsible for heme transport. Perhaps 
the observation of growth phases is misleading, and actually counterintuitive to that which is 
physiologically relevant. For instance, there are probably low iron requirements for the brucellae 
as they first enter the macrophage, making more of a stationary phase phenotype that requires the 
presence of RirA. In other alpha proteobacteria, the absence of RirA has been linked to an 
increase in sensitivity to hydrogen peroxide (Ngok-Ngam 2009), and the presence of this 
regulator during a time when the brucellae would encounter the oxidative burst of the 
macrophage would make sense. Under these conditions, RirA would repress both bhuTUV and 
siderophore biosynthesis genes, since the uptake of iron during oxidative stress could be 
detrimental to the brucellae.  
As the brucellae travel within the phagosome toward the endoplasmic reticulum (ER), it 
would become more iron-starved, allowing for the presence of Irr. Irr would repress rirA 
expression, as well as bhuTUV, since there would be little if any heme to transport. However, Irr 
would turn on bhuA expression, and as soon as the brucella-containing phagosome fused with the 
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ER, BhuA would begin to take heme into the periplasm of the cell. Through low levels of 
bhuTUV expression, cellular iron levels would increase and Irr levels would decrease, allowing 
for greater transcription of bhuTUV, and ultimately bringing more heme iron into the cell. This 
use of heme as an iron source would allow for the Brucella replication seen in the ER niche, 
which more closely resembles the log phase of growth seen in vitro (Köhler 2003). This is at best 
a hypothesis, and current work in our lab is aimed at understanding this regulatory loop. 
The experimental findings presented here give a more complete picture of the genes 
involved with heme transport in B. abortus. While we can only postulate what other sources of 
iron these bacteria come into contact with during the course of infection, it is clear that no other 
iron source can take the place of heme. The ability of the brucellae to utilize heme as an iron 
source in vivo is paramount to the continuance of chronic infection in the mouse model, a model 
which may provide relevant insights into the chronic brucellosis disease acquired by humans. 
Therefore strains defective in their ability to use heme as an iron source may present viable 
options for vaccine development in the future. Also, the heme utilization components may make 
good targets for the development of antimicrobials, eliminating the need for the current intensive 
antibiotic regimen for brucellosis. 
74 
 
Acknowledgements 
This work was supported by a grant from National Institute of Allergy and Infectious 
Disease (AI 63516) to R.M.R. II. 
References 
Anderson ES. 2006. Identification of the AraC-like transcriptional regulator DhbR and its role 
in the regulation of the genes required for siderophore biosynthesis in Brucella abortus. 
Dissertation. East Carolina University Brody School of Medicine. 
 
Anderson ES, Paulley JT, Martinson DA, Gaines JM, Steele KH and Roop 2
nd
 RM. 2011. 
The iron-responsive regulator Irr is required for wild-type expression of the gene encoding the 
heme transporter BhuA in Brucella abortus 2308. J. Bacteriol. 193: 5359-5364. 
 
Andrews SC, Robinson AK and Rogriguez-Quinones F. 2003. Bacterial iron homeostasis. 
FEMS Microbiol. Rev. 27:215-237. 
 
Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, Memish ZA,  
Roushan MRH, Rubinstein E, Sipsas NV, Solera J, Young EJ and Pappas G (2007). 
Perspectives for the treatment of brucellosis in the 21
st
 century: the Ioannina recommendations. 
PLoS Medicine 4:e317. 
 
Bellaire BH,  Elzer PH,  Baldwin CL and Roop 2
nd
 RM. 2003. Production of the siderophore 
2,3-dihydroxybenzoic acid is required for wild-type growth of  Brucella abortus in the presence 
of  erythritol under low-iron conditions in vitro. Infect. Immun. 71:2927-2932. 
 
76 
 
Burkhard KA and Wilks A. 2008. Functional characterization of the Shigella dysenteriae heme 
ABC transporter. Biochemistry. 47:7977 - 7979. 
 
Byrd TF and Horwitz MA. 1989. Interferon gamma-activated human monocytes downregulate 
transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by 
limiting the availability of iron. J Clin Invest. 83:1457-65. 
 
Caswell CC, Gaines JM and Roop RM 2
nd
. 2012. The RNA chaperone Hfq independently 
coordinates expression of the VirB type IV secretion system and the LuxR-type regulator BabR 
in Brucella abortus 2308. J Bacteriol. 194: 3-14. 
 
Cellier MF, Courville P and Campion C. 2007. Nramp1 phagocytic intracellular metal 
withdrawal defense. Microbes Infect. 9:1662-1670. 
 
Cobessi D, Meksem A and Brillet K. 2010. Structure of the heme/hemoglobin outer membrane 
receptor ShuA from Shigella dysenteriae: heme binding by an induced fit 
mechanism.Proteins. 78:286-294. 
 
Crichton RR, Wilmet S, Legssyer R and Ward RJ. 2002. Molecular and cellular mechanisms 
of iron homeostasis and toxicity in mammalian cells. J. Inorg. Biochem. 91:9-18. 
77 
 
 
Delpino MV, Cassataro J, Fossati CA, Goldbaum FA and Baldi PC. 2006. Brucella outer 
membrane protein Omp31 is a haemin-binding protein. Microbes and Infection. 8:1203-1208. 
 
Eakanunkul S, Lukat-Rodgers GS, Sumithran S, Ghosh A, Rodgers KR, Dawson JH and 
Wilks A. 2005. Characterization of the periplasmic heme-binding protein ShuT from the heme 
uptake system of Shigella dysenteriae Biochemistry 44:13179 - 13191. 
 
Elzer PH, Phillips RW, Kovach ME, Peterson KM and Roop 2
nd
 RM. 1994. Characterization 
and genetic complementation of a Brucella abortus high-temperature-requirement A (htrA) 
deletion mutant. Infect. Immun. 62:4105–4110. 
 
Frankenberg-Dinkel N. 2004. Bacterial heme oxygenases. Antioxid Redox Signal. 6:825-834. 
 
Gee JM, Valderas MW, Kovach ME, Grippe VK,  Robertson GT, Ng WL, Richardson JM, 
Winkler ME and Roop 2
nd
 RM. 2005. The Brucella abortus Cu/Zn superoxide dismutase is 
required for optimal resistance to oxidative killing by murine macrophages and wild-type 
virulence in experimentally infected mice. Infect. Immun. 73:2873–2880. 
 
Gerhardt P, Tucker LA and Wilson JB. 1950. The nutrition of Brucellae: utilization of single 
amino acids for growth. J. Bacteriol. 59:777-782. 
 
78 
 
Hibbing ME and Fuqua C.2011. Antiparallel and interlinked control of cellular iron levels by 
the Irr and RirA regulators of Agrobacterium tumefaciens. J Bacteriol. 193:3461-3472. 
 
Kirby AE, Metzger DJ, Murphy ER and Connell TD. 2001. Heme Utilization in Bordetella 
avium Is Regulated by RhuI, a Heme-Responsive Extracytoplasmic Function Sigma Factor. 
Infect and Immun. 69:6951-6961. 
 
Köhler S, Michaux-Charachon S, Porte F, Ramuz M and Liautard JP. 2003. What is the 
nature of the replicative niche of a stealthy bug named Brucella? Trends Microbiol. 11:215-219. 
 
Kovach ME, Elzer PH,  Hill DS,  Roop 2
nd
 RM and Peterson KM. 1995. Four new 
derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic 
resistance cassettes. Gene. 166:175–176. 
 
Nairz M, Schroll A, Sonnweber T and Weiss G (2010). The struggle for iron – a metal at the 
host-pathogen interface. Cellular Microbiology 12:1691-1702. 
 
Ngok-Ngam P, Ruangkiattikul N, Mahavihakanont A, Virgem SS, Sukchawalit R and 
Mongkolsuk S. 2009. Roles of Agrobacterium tumefaciens RirA in iron regulation, oxidative 
stress response, and virulence. J Bacteriol. 191:2083-2090. 
 
79 
 
Paulley JT, Anderson ES and Roop 2
nd
 RM. 2007. Brucella abortus requires the heme 
transporter BhuA for maintenance of chronic infection in BALB/c mice. Infect. Immun. 75: 
5248–5254. 
 
Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. 
Nucleic Acids Res. 29:2002–2007. 
 
Robertson GT, Kovach ME, Allen CA, Ficht TA and Roop RM 2
nd
. 2000. The Brucella 
abortus Lon functions as a generalized stress response protease and is required for wild-type 
virulence in BALB/c mice. Mol Microbiol. 35:577-588. 
 
Roop 2
nd
 RM, Anderson E, Ojeda J, Martinson D, Menscher E and Martin DW. 2011. 
Metal acquisition by Brucella strains. I. López-Goñi and D. O’Callaghan (eds.), Brucella: 
molecular microbiology and genetics, Horizon Scientific Press, Norfolk, UK. 179-199.   
  
Rosner B. 2000. Fundamentals of biostatistics, 5th ed. Duxbury, Pacific Grove, CA. 
 
Rudolph G, Semini G, Hauser F, Lindemann A, Friberg M, Hennecke H and Fischer HM. 
2006. The iron control element, acting in positive and negative control of iron-regulated 
Bradyrhizobium japonicum genes, is a target for the Irr protein. J Bacteriol. 188:733-744. 
80 
 
 
Siudeja K and Olczak T. 2005. Mechanisms and regulation of iron and heme utilization in 
gram-negative bacteria. 51:198-208.  
 
Spratt BG, Hedge PJ, Heesen ST, Edelman A and Broome-Smith JK. 1986. Kanamycin-
resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9. Gene. 
41:337-342. 
 
Staggs TM and Perry RD. 1991. Identification and cloning of a fur regulatory gene in Yersinia 
pestis. J. Bacteriol. 173:417–425. 
 
Torres AG and Payne SM. 1997. Haem iron-transport system in enterohaemorrhagic 
Escherichia coli O157:H7. Mol. Microbiol. 23:825–833. 
 
Wyckoff EE, Duncan D, Torres AG, Mills M,  Maase K and Payne SM. 1998. Structure of 
the Shigella dysenteriae haem transport locus and its phylogenetic distribution in enteric 
bacteria. Mol. Microbiol. 28:1139–1152. 
 
Yeoman KH, Curson ARJ, Todd JD, Sawers G and Johnston AWB . 2004.  Evidence that 
the Rhizobium regulatory protein RirA binds to cis-acting iron-responsive operators (IROs) at 
promoters of some Fe-regulated genes. Microbiology. 150:4065–4074. 
81 
 
Table 2.1. Bacterial strains used in this study.
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 TABLE 2.1. Bacterial strains used in this study  
Strain or plasmid Genotype or description Reference or source 
Strains   
Escherichia coli    
DH5α F¯ φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 
hsdR17(rK¯ mK⁺) phoA supE44 thi-1 gyrA96 relA1 λ¯ 
Invitrogen 
Brucella abortus   
2308 Virulent challenge strain Laboratory stock 
JFO2 705 bp gene deletion of bhuTUV (BAB2_0483-0485) with 
an ahpA3 kanamycin resistance gene insertion 
This study 
JFO2RC JFO2 with bhuTUV (BAB2_0483-0485) reconstructed onto 
the chromosome using pNPTS138 
This study 
BEA2 Δirr Anderson 2011, this 
study 
BEA4 ΔrirA This study 
Plasmids   
pGEM-T Easy ColE1-based cloning vector; ampicillin resistance Promega 
pKS + Kan 794-bp aphA3 gene from TnphoA cloned into SalI-HindIII-
digested pBluescript II KS+ 
Kovach, 1995 
pNPTS138 sacB-containing counterselection vector; ampicillin 
resistance 
Spratt, 1986 
 
 
Table 2.1
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Table 2.2. Primers used in this study. 
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TABLE 2.2. Primers used for this study 
REV 5’ –AATGCATCAAATGGCAGGCA -3’ 
bhuTUV-1F 5’-GAAGATCTTCTCGTGATCTTGTCCGC-3’ 
bhuTUV-1R 5’-CGGTTTTGCGAGGCATC-3’ 
bhuTUV-2F 5’- CCGTAAAACGCAAGTTTCTGG-3’  
bhuTUV-2R 5’- ATGAGGGGATCGTCTGGAGC-3’ 
amp - F 5’-TATTTCGTTCATCCATA-3’ 
amp - R 5’-GTTTTCCAATGATGAGC-3’ 
Kan R 5’-CCACTCCAGCATGAGAT-3’ 
16S Fwd    5’-TCTCACGACACGAGCTGACG-3’ 
16S Rev 5’-CGCAGAACCTTACCAGCCCT-3’ 
bhuT Fwd 5’-TGGGTCTCGGTGACAGGGTT-3’ 
bhuT Rev 5’-TCACATTCCTGATGCCGAGC-3’ 
 
 
 
 
 
 
 
Table 2.2 
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Figure 2.1. Genetic organization of the heme transport genes in B. abortus 2308. (A) 
Brucella heme transport genes are located in separate areas of the chromosome. BAB2_1148 and 
BAB2_1149 are predicted to encode cytoplasmic transporters but do not encode conserved heme 
transport motifs. The black arrows indicate which genes are cotranscribed in an operon. (B) 
Reverse transcription PCR of bhuTUV and surrounding genes shows that the ORFs designated 
hyp, bhuT, bhuU, and bhuV are cotranscribed. Lanes are marked for ladder (L) and #1-6 are the 
intragenic regions denoted by the arrows in part (A). (C) Real time PCR of BAB2_1148, 
BAB2_1149, bhuT and bhuA transcripts in low iron medium compared to low iron medium 
containing 50 µM FeCl3 which shows the iron-responsive nature of bhuA and bhuT, but lack of 
iron-responsiveness of BAB2_1148 and BAB2_1149. (D) Amino acid alignments of BhuT and 
ShuT as well as BhuU and ShuU.  
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Figure 2.1 
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Figure 2.2. The bhuTUV mutant exhibits a growth defect during iron deprivation that can 
be rescued by FeCl3, but not heme or hemoglobin. Growth of B. abortus 2308 (triangles), B. 
abortus JFO2 (2308 bhuTUV) (squares and dashed lines), and JFO2RC (JFO2 bhuTUV+) 
(circles) in (A) low iron minimal medium, (B) low iron minimal medium containing 50 µM 
FeCl3, (C) low iron minimal medium containing 25 µM hemin, and (D) low iron minimal 
medium containing 25 µM hemoglobin. The data presented are from one experiment, but 
representative of multiple experiments (>3) from which similar trends were observed.  ** = P < 
0.001 for comparisons of the data obtained for these strains in the Student’s two-tailed t-test 
(Rosner, 2000). 
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Figure 2.2 
89 
 
Table 2.3 Capacity of the bhuTUV mutant to use heme and FeCl3 as iron sources in a solid 
medium-based assay. Strains were spread onto chelated (125 µM EDDHA) tryptic soy agar 
plates following 72 h growth in low iron minimal medium. Either deferrated hemin or ferric 
chloride was added to paper discs and growth around the disks was measured in millimeters 
(mm). The data presented is representative of multiple experiments (>3) from which similar 
trends were observed.   
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Table 2.3  
 
Strain 
Heme 
(mm) 
FeCl3 
(mm) 
B. abortus 2308 25.5 44.3 
bhuA 0 25 
bhuTUV 0 45 
bhuTUV – RC 26 44.7 
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Figure 2.3 bhuT transcription is iron-responsive in B. abortus 2308 and regulated by both 
Irr and RirA. The fold induction presented on the Y- axis represents the difference between the 
levels of bhuT transcripts detected by real-time RT-PCR in RNA preparations from cultures after 
72 h and 120 h of growth in low-iron minimal medium compared to low iron medium plus 50 
µM FeCl3 in B. abortus 2308 (black), BEA4 (rirA-) (grey), and BEA2 (irr-) (light grey). Both 
transcripts were normalized against the 16S ribosomal RNA housekeeping gene, whose 
expression is not altered by the conditions.   
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Figure 2.3 
Chapter 3: The bhuO gene encodes a heme oxygenase that 
contributes to the ability of Brucella abortus 2308 to use heme as an 
iron source and is regulated by Irr 
Abstract 
 The Brucella BhuO protein is a homolog of the Bradyrhizobium japonicum heme oxygenases 
HmuD and HmuQ. To determine if this protein plays a role in the ability of Brucella abortus 
2308 to use heme as an iron source, an isogenic bhuO mutant was constructed and its phenotype 
evaluated. Although the B. abortus bhuO mutant DCO1 did not exhibit a defect in its capacity to 
use heme as an iron source nor evidence of  increased heme toxicity in vitro, this mutant 
produced increased levels of  siderophore in response to iron deprivation compared to 2308. 
Introduction of a bhuO mutation into the B. abortus dhbC mutant BHB2 (which cannot produce 
siderophores) resulted in a severe growth defect in the dhbC bhuO double mutant JFO1 during 
cultivation under iron restricted conditions, which could be rescued by the addition of FeCl3, but 
not heme, to the growth medium. The bhuO gene is co-transcribed with the gene encoding the 
iron-responsive regulator RirA, and both of these genes are repressed by the other major iron-
responsive regulator in the –proteobacteria, Irr. The results of these studies suggest that B. 
abortus 2308 has at least one other heme oxygenase that works in concert with BhuO to allow 
this strain to efficiently use heme as an iron source. The genetic organization of the rirA-bhuO 
operon also provides the basis for the proposition that BhuO may perform a previously 
unrecognized function by allowing the transcriptional regulator RirA to recognize heme as an 
iron source. 
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Introduction 
 Iron represents an essential micronutrient for Brucella strains (Roop 2011). Acquiring 
sufficient iron to meet their physiological needs is particularly challenging for the brucellae 
because these bacteria are found in nature almost exclusively in mammalian hosts, an 
environment where the iron restriction faced by pathogenic microbes is well documented 
(Schaible 2004). Brucella strains can use heme as an iron source in vitro, and studies with an 
isogenic mutant have shown that the presence of the TonB-dependent outer membrane heme 
transporter BhuA is required for the wild-type virulence of B. abortus 2308 in experimentally 
infected mice (Paulley 2007), suggesting that heme is a biologically relevant source of iron for 
the brucellae during infection.  
 Heme oxygenases catalyze the release of iron from heme, and these enzymes contribute to 
the ability of a variety of bacteria to utilize heme as an iron source (Schmitt 1997; Zhu 2000; 
Ratliff 2001).  The product of the gene designated BMEII0706 in the B. melitensis 16M genome 
sequence shares 58 and 50% amino acid identity with the heme oxygenases HmuD and HmuQ, 
respectively, from Bradyrhizobium japonicum, and this Brucella protein exhibits heme 
oxygenase activity in an in vitro assay (Puri 2006).  Based on its documented biochemical 
activity, we have given this protein the designation BhuO (Brucella heme utilization oxygenase). 
The purpose of the experiments described in this report was to determine if the homologous 
protein in B. abortus 2308 (which is encoded by BAB2_0677) plays a role in the capacity of this 
strain to use heme as an iron source. 
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Materials and Methods 
Bacterial strains, media, and growth conditions. Brucella abortus strains (Table 3.1) were 
routinely grown in brucella broth at 37C with aeration, or on Schaedler agar supplemented with 
5% bovine blood (SBA) at 37C under 5% CO2. Kanamycin (45 g/ml) (Sigma) and/or 
ampicillin (25 g/ml) (Sigma) were added to these media as appropriate for the selection of 
strains with antibiotic resistance markers. Escherichia coli strain DH5 was used for the 
propagation of plasmids for procedures involving recombinant DNA, and this strain was 
cultivated at 37C in LB broth or on LB agar plates containing either 100 g/ml ampicillin, or 45 
g/ml kanamycin when appropriate. Gerhardt’s minimal medium (GMM) (Gerhardt 1950) and 
low iron minimal medium (López-Goñi 1992) were prepared as previously described.  
  
Construction of a B. abortus bhuO mutant and a dhbC bhuO double mutant. 
  Polymerase chain reaction (PCR) utilizing Taq polymerase (Invitrogen) with the 
oligonucleotide primers bhuO-1F and bhuO-1R (Table 3.2) was used to amplify a 1605 bp 
fragment encompassing the bhuO gene (BAB2_0677) from B. abortus 2308 genomic DNA. This 
fragment was then cloned into pGEM
®
-T Easy (Promega).  Inverse PCR employing AccuPrime 
Pfx supermix (Invitrogen) with this plasmid as a template and the primers bhuO-2F and bhuO-2R 
(Table 3.2) was then employed to generate a blunt-ended linear fragment from which 70 bp 
internal to the bhuO coding region had been removed. This fragment was ligated with a 1345 bp 
fragment containing the aph3a gene from pKS-Kn (Kovach 1995). The resulting construct, 
pGEMΔbhuO, was introduced into B. abortus strain 2308 by electroporation and transformants 
were selected on SBA supplemented with 45 µg/ml kanamycin. Putative B. abortus bhuO 
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deletion mutants were identified based on their resistance to kanamycin and sensitivity to 
ampicillin, and their genotypes confirmed by PCR analysis and DNA sequence analysis. 
Chromosomal DNA preparations from putative deletion mutants and strain 2308 were harvested 
and oligonucleotides bhuO F1 and Kan R (Table 3.2) were used to determine the presence of the 
aph3a-based gene in the proper orientation, the absence of the ampicillin resistance gene from 
pGEM
®
-T Easy (Promega) (amp F and amp R), and the absence of the 70 bp in the middle of 
bhuO (bhuO F1 and bhuO R1). One confirmed B. abortus bhuO mutant was selected for further 
phenotypic evaluation and given the designation DCO1.  
 The approach described in the previous paragraph was also used to introduce a bhuO 
mutation into B. abortus BHB2 (Bellaire 2003). BHB2 has an unmarked, in frame deletion in its 
dhbC gene, which renders it unable to produce either of the two siderophores produced by 
Brucella strains – 2,3-dihydroxybenzoic acid (López-Goñi 1992) or brucebactin (Gońzalez-
Carrero 2002). The B. abortus dhbC bhuO double mutant constructed in this fashion was given 
the designation JFO1. 
  
Reconstruction of the bhuO loci in the B. abortus bhuO and dhbC bhuO mutants.   
 Because the bhuO gene is the terminal gene in an operon and lies downstream of  a 
transcriptional regulator (Figure 3.4), reconstruction of  the mutated bhuO genes in DCO1 and 
JFO1 was chosen as a strategy for verifying the link between genotype and the phenotypes 
exhibited by these strains, rather than genetic complementation with a plasmid-borne bhuO gene. 
A 920 bp fragment encompassing the bhuO gene from B. abortus strain 2308 genomic DNA was 
amplified by PCR using the primers bhuO-3F and bhuO-3F (Table 3.2) and cloned into the 
BamHI and SalI sites of pNPTS138Ap (Table 3.1), an ampicillin–resistant derivative of the 
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sacB-containing ColE1-based vector pNPTS138 (Spratt 1986). The resulting plasmid, designated 
pNPTS138bhuO was introduced into B. abortus DCO1 and JFO1 by electroporation, and a 
previously described sacB-based counterselection strategy (Bellaire 2003) was used to select for 
derivatives of these mutants in which the mutated bhuO genes had been replaced by the parental 
bhuO gene. The genotypes of the resulting B. abortus strains, designated DCO1RC and JFO1RC 
were confirmed by PCR amplification and DNA sequence analysis. 
   
Measurement of siderophore production by Brucella strains. 
 Following growth of the B. abortus strains in low iron minimal medium (López-Goñi et al., 
1992) at 37°C with shaking (165 rpm), bacterial cells from 1.5 ml portions of the cultures were 
pelleted by centrifugation (15,550 X g, 1 min, room temperature), 1 ml of the resulting 
supernatant removed to a fresh tube (10 ml), and the level of catechol siderophore present 
measured using the Arnow assay (Arnow 1937). 
 
Determination of the growth characteristics of B. abortus strains in an iron limited culture 
medium. 
 B. abortus strains were grown on SBA plates at 37°C with 5% CO2 for 48 h and harvested 
into PBS. The resulting cell suspensions were used to inoculate 25 ml low iron minimal medium 
in 125 ml Erlenmeyer flasks at a final concentration of approximately 10
6
 CFU/ml. When 
applicable, the medium was supplemented with either 50 M FeCl3 or 25M deferrated hemin 
(Staggs 1991). Cultures were incubated at 37°C with shaking at 165 rpm, and at 24 hour time 
points post inoculation these cultures were serially diluted in PBS and plated on SBA, followed 
by incubation at 37°C under 5% CO2. 
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Relative quantification of bhuO transcript levels using real-time RT-PCR.  
B. abortus 2308 and BEA2 (2308 irr) (Anderson 2011) were grown in low-iron minimal 
medium and low-iron minimal medium
 
supplemented with 50 µM FeCl3,  or Gerhardt’s Minimal 
Medium with or without 25 µM deferrated hemin. Total cellular RNA was isolated from these 
cultures using a previously described procedure (Caswell 2012). The RNA was treated with
 
RQ1 
DNase (Ambion) following the manufacturer's instructions
 
to remove residual contaminating 
DNA. The absence of DNA from
 
the RNA preparations was confirmed via PCR analysis and 
lack of an amplified product as visualized on an agarose gel confirmed that the RNA sample was 
free of DNA contamination. Concentrations of RNA
 
in the samples were determined by 
measuring the absorbance at
 
260 nm using a NanoDrop ND-1000 Spectrophotometer.
 
 
The SuperScript III First-Strand Synthesis System for RT-PCR kit (Invitrogen) was used 
to convert 1 µg of RNA from these preparations into cDNA for each preparation
 
following the 
manufacturer's instructions and using the random
 
hexamers supplied with the kit. The cDNA 
preparations were then
 
used as the templates in real-time RT-PCR analysis along with FastStart 
SYBR Green Master 2X (Roche) to evaluate
 
the relative levels of gene-specific mRNA 
transcripts in the
 
total cellular RNA preparations. Gene-specific oligonucleotide
 
primers were 
utilized for the following genes 16S, dhbC, bhuA, and bhuO (see Table 3.2). The differences in 
the levels of the bhuO-, bhuA-, and dhbC -specific transcripts present were calculated using 
methods described by Pfaffl (Pfaffl 2001), using the 16S gene as an internal standard. This gene 
encodes the ribosomal 16S protein, and its expression is constitutive in B. abortus 2308 under 
the experimental conditions used here.  
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Determination of the operonic organization of the ybaK, rirA, bhuO, and bfr genes in B. 
abortus 2308. 
 Reverse transcriptase PCR was performed using cDNA prepared from clean RNA harvested 
from B. abortus 2308 grown for 72 h in low iron medium. Primers that span the intragenic 
regions between ybaK (BAB2_0679), rirA (BAB2_0678), bhuO (BAB2_0677), and bfr 
(BAB2_0676) (Table 3.2) were used in order to verify the presence or absence of a continuous 
transcript containing these genes. The resulting PCR products were separated by electrophoresis 
in a 0.7% agarose gel and visualized by staining the gel with ethidium bromide. 
 
Determination of the transcriptional start site for the rirA-bhuO operon. 
 The bhuO gene is co-transcribed with the upstream gene, rirA. In order to determine a 
transcriptional start site for this operon, 5’ RNA ligase mediated rapid amplification of the 
cDNA end (5’ RLM-RACE) was performed using a primer (Rev) anchored in the reverse 
orientation within the rirA ORF following the manufacturer’s instructions (FirstChoice RLM-
RACE Kit, Ambion, AM1700).  The PCR product generated from this reaction was cloned into 
pCR2.1 (Invitrogen), and the authenticity of the PCR fragment verified by DNA sequence 
analysis. 
 
Identification of the Irr binding site in the rirA promoter region. 
A recombinant version of the Brucella Irr was purified, and used in a DNase I footprint 
analyis with the rirA promoter region from B. abortus 2308 using previously described methods 
(Anderson 2011; Menscher 2012). Briefly, the oligonucleotide primers rirA F and rirA R (Table 
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3.2) were individually labeled with [γ-32P]ATP (Perkin Elmer) using the T4 polynucleotide 
kinase reaction (Promega, Madison, WI) prior to their use in PCR reactions with Pfx polymerase 
to generate 300-bp DNA fragments representing the rirA promoter and transcriptional start site. 
The resulting PCR products were subjected to agarose gel electrophoresis and purified by gel 
extraction (Fermentas, Glen Burnie, MD). DNA probes corresponding to 8,000 cpm of the 
forward labeled and reverse labeled templates were incubated separately in EMSA binding 
buffer (10 mM Tris-HCl, pH 8, 40 mM KCl, 1 mM MgCl2, 1 mM dithiothreitol [DTT], 5% 
glycerol) supplemented with 100 ng/ml bovine serum albumin (BSA) and 50 ng/ml salmon 
sperm DNA (nonspecific competitor) in the presence of 100 μM MnCl2 and increasing 
concentrations of the recombinant Brucella Irr protein. The reaction mixtures  were incubated at 
room temperature for 30 min prior to treatment with 0.08 U of DNase I freshly diluted in 10× 
DNase I buffer (400 mM Tris-HCl [pH 8.0], 100 mM MgSO4, 10 mM CaCl2) for 4 min. 
Reactions were stopped by the addition of 5 mM EDTA and heating at 65°C for 10 min. 
Reaction mixtures were ethanol precipitated and resuspended in 4 μl of formamide loading 
buffer (98% formamide, 10 mM EDTA [pH 8.0], 1 mg/ml xylene cyanol FF, 1 mg/ml 
bromophenol blue). Digested DNA fragments were separated on a denaturing 6% (wt/vol) 
acrylamide and 7 M urea sequencing gel in glycerol-tolerant buffer (Menscher 2012). Gels were 
dried under vacuum dryer and subjected to autoradiography. The sequence protected by Irr was 
determined by comparing the nucleotide sequences generated for a 100-bp region of the rirA 
promoter region using the SequiTherm Excel II DNA sequencing kit (Epicentre, Madison, WI) 
and B. abortus 2308 DNA preparations exposed to DNase I treatment with and without 
recombinant Irr as templates.  
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Statistical analysis. 
All statistical analysis was performed using the Student’s two-tailed t-test. P values of 
less than 0.05 were considered significant (Rosner 2000).  
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Results and Discussion 
Pfam analysis of the Brucella BhuO protein indicates that it belongs to the antibiotic 
monooxygenase (ABM) family of heme oxygenases along with the HmuD and HmuQ proteins 
from B. japonicum (Puri 2006) and the IsdI and IsdG proteins from Staphylococcus aureus 
(Skaar 2004). Moreover, BhuO contains the conserved Asn 7, Trp 67 and His 77 residues shown 
experimentally to be important for the heme oxygenase activity of IsdG (Wu 2005) (Figure 3.1), 
and BhuO has been shown to bind and degrade heme in vitro (Puri 2006). Despite the 
documuented heme oxygenase activity of BhuO, a bhuO mutant (DCO1) constructed from B. 
abortus 2308 exhibited a comparable growth pattern in low iron minimal medium (López-Goñi 
1992) and an equivalent resistance to the iron specific chlelator ethylenediamine-N,N'-bis(2-
hydroxyphenylacetic acid) (EDDHA) (Rogers 1973) to that displayed by the parental strain. 
More importantly, both strains were also able to use heme as an iron source with equivalent 
efficiency in a chelator based disk assay on a solid growth medium (Paulley 2007) (data not 
shown).  
A distinctive characteristic of the B. abortus bhuO mutant that was noticed during its 
phenotypic characterization, however, was that this mutant consistently and reproducibly 
produced more siderophore during growth in low iron minimal medium than the parental 2308 
strain (Figure 3.2A). This increase in siderophore production was accompanied by a 
corresponding increase in transcription of dhbC in the bhuO mutant in comparison to the parental 
strain (2308) following growth under iron limiting conditions (Figure 3.2B). This phenotype 
suggests that the B. abortus bhuO mutant is experiencing a greater degree of iron deprivation in 
the low iron minimal medium than 2308, and in turn increases its siderophore production to 
compensate. Enhanced siderophore production could explain why the B. abortus bhuO mutant 
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does not exhibit a readily detectable iron acquisition defect in in vitro assays such as growth in 
low iron minimal medium or sensitivity to EDDHA. The ability of this mutant to use heme as an 
iron source in the disk diffusion assays, however, indicates that B. abortus 2308 possesses one or 
more additional heme oxygenases that can compensate for the loss of BhuO and allow the bhuO 
mutant to use heme as an iron source. The identity of these other heme oxygenases is currently 
unknown.  
 Brucella strains have the capacity to use multiple iron sources during in vitro growth (Roop 
2011), and it is not usual for bacterial strains with mutations affecting single iron transporters to 
exhibit little or no defect in iron utilization assays due to compensation by other iron transport 
systems. Indeed, the fact that the B. abortus bhuO mutant exhibits increased siderophore 
production in response to iron deprivation compared to the parental strain provides a potential 
experimental avenue for assessing the role of BhuO in iron metabolism. Specifically, if the loss 
of BhuO from B. abortus DCO1 is leading to an increased demand for iron, and siderophore 
production is being increased in this mutant to meet this demand, then a derivative of this strain 
that cannot produce siderophore (e.g. a B. abortus dhbC bhuO double mutant) would be expected 
to show an enhanced iron deprivation phenotype compared to B. abortus 2308 or the bhuO 
mutant when grown under iron limiting conditions.  This is in fact the relationship that was 
observed. As shown in Figure 3.3A, the dhbC bhuO double mutant JFO1 showed a greatly 
enhanced growth defect compared to the parental BHB2 (dhbC mutant) strain when they were 
cultivated in low iron minimal medium, a phenotype that was not observed when these strains 
were grown in iron-replete medium (Figure 3.3B). More importantly, the enhanced growth 
defect exhibited by the B. abortus dhbC bhuO double mutant during cultivation in low iron 
minimal medium could be rescued by the addition of FeCl3 (Figure 3.3C), but not heme (Figure 
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3.3D), to the growth medium 48 hours after inoculation of the bacterial cultures. In contrast, 
either FeCl3 (Figure 3.3C) or heme (Figure 3.3D) was able to rescue the growth defect exhibited 
by the dhbC mutant BHB2 during growth under low iron conditions. To verify the link between 
the bhuO mutations in B. abortus DCO1 and JFO1 and the phenotypes exhibited by these strains, 
a sacB-based counterselection strategy (Bellaire 2003) was used to reconstruct the bhuO genes in 
these mutants. The resulting strains, designated DCO1RC and JFO1RC, exhibited the expected 
parental phenotype with regard to their production of siderophore in response to iron deprivation 
(Figure 3.2), sensitivities to iron deprivation (Figures 3.3A and 3.3B) and their abilities to use 
FeCl3 and heme as iron sources (Figures 3.3C and 3.3D). Although these experimental findings 
establish a role for BhuO in the capacity of the B. abortus dhbC mutant to use heme as an iron 
source, this activity appears to be masked in B. abortus 2308 by the activity of other heme 
oxygenases when alternative iron sources are readily available in the growth medium. The 
capacity of  the B. abortus bhuO mutant to compensate for the loss of one heme oxygenase was 
also observed in experimental models of  infection, as this strain exhibited wild-type virulence in 
cultured murine macrophages and experimentally infected BALB/c mice (data not shown).   
RT-PCR analysis indicates that bhuO is the last gene in an operon transcribed as rirA 
(BAB2_0678) - bhuO (BAB2_0677) in B. abortus 2308 (Figure 3.4). RirA is a well-
characterized regulator of iron metabolism genes in several of the other –proteobacteria (Todd  
2002; Chao 2005; Ngok-Ngam 2009; Hibbing 2011). A predicted iron control element (ICE) 
motif is located in the (-10) region of the promoter of the rirA-bhuO operon (Figure 3.4), 
suggesting that the iron response regulator Irr regulates the expression of these genes in response 
to cellular iron levels (Martínez  2006). In fact, when the expression patterns of the rirA and 
bhuO genes in B. abortus 2308 were independently evaluated by real time PCR, both genes 
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exhibited a modest induction in response to iron deprivation (Figure 3.5). In contrast, the 
expression of both of these genes was elevated >50 fold in the B. abortus irr mutant BEA2 when 
this strain was grown under iron limiting conditions. Thus, it appears as if Irr represses the 
expression of  rirA in Brucella strains during periods of  iron deprivation in much the same 
manner as it does in the related –proteobacterium Agrobacterium tumefaciens (Hibbing 2011). 
Rodionov et al predicted a conserved ICE motif in the promoter region of rirA (underlined 
below) (Rodionov 2006). To investigate this possible direct interaction, DNase footprint analysis 
was used and indicated that Irr directly binds to the rirA promoter (Figure 3.6), protecting a 28 
nucleotide sequence, 5’-CATATATTTTAAGAATGATTCTAAAGTG-3’.  
Genetic studies suggest that RirA functions as an iron-responsive repressor of iron 
acquisition genes in the –proteobacteria (Todd 2002), in much the same fashion as Fur does in 
other bacteria. The potential benefit of Irr repressing the expression of an iron-responsive 
repressor when the bacterial cell is experiencing iron-deprivation is not difficult to envision. But 
such a regulatory link would appear to be counterproductive for the bhuO gene if its product is 
solely dedicated the utilization of heme as an iron source. One scenario that might explain a 
possible benefit of co-regulation of bhuO and rirA in B. abortus 2308 is that heme oxygenases 
such as BhuO may have a secondary function in this strain. Specifically, it is conceivable that the 
release of iron from heme catalyzed by these enzymes allows RirA to recognize the utilization of 
heme as an iron source and represses the cell’s iron acquisition systems accordingly (Figure 3.7). 
In addition to their ability to provide iron from heme, some bacterial heme oxygenases also 
function to protect the cell against heme toxicity (Anzaldi 2010). Heme has a high redox 
potential, and too much heme inside a bacterial cell can be toxic (Nir 1991). Neither B. abortus 
2308 nor the isogenic bhuO mutant display a growth defect in low iron medium supplemented 
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with up to 200 µM deferrated hemin. It is possible, however, that any role that BhuO might be 
playing in the detoxification of heme is masked by the activity of another heme oxygenase. 
Another factor that may affect this observed lack of heme toxicity is that Brucella strains possess 
multiple homologs of the outer membrane heme-binding proteins (Hbps) that have been 
proposed to play a role in capturing heme and preventing its toxicity in Bartonella (Minnick 
2009). In Brucella, these proteins are known as the Omp25/31 family of proteins (Cloeckaert 
1996). Heme export systems have also been proposed as a means by which bacteria protect 
themselves from heme toxicity (Anzaldi 2010). Although a heme exporter has not been identified 
in Brucella strains, genes that potentially encode orthologs of proteins linked to porphyrin 
(Tatsumi 2008) and heme (Rasmussen 2005) export in other bacteria can be found in the genome 
sequence of B. abortus 2308. 
 In order to fully understand the role of BhuO in iron and heme metabolism in Brucella 
strains, it will be imperative to identify the other heme oxygenase(s) present in these bacteria. 
Phenotypic evaluation of mutants lacking combinations of these enzymes can then be used to 
assess the relative contributions of the heme oxygenases to iron and heme metabolism, as well as 
their potential role in modulating the regulatory capacity of RirA. Such studies may also provide 
an added practical benefit, as prokaryotic heme oxygenases have been proposed to be targets for 
the development of antimicrobial agents (Furci 2007). Brucellosis in humans is notoriously 
difficult to treat, requiring a combination of antibiotics for a prolonged period (Ariza 2007). 
Hence, the development of improved chemotherapeutic regimens for treating this disease would 
of great benefit to the medical community.  
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 TABLE 1. Bacterial strains used in this study  
Strain or plasmid Genotype or description Reference or source 
Strains   
Escherichia coli    
DH5α F¯ φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 
hsdR17(rK¯ mK⁺) phoA supE44 thi-1 gyrA96 relA1 λ¯ 
Invitrogen 
Brucella abortus   
2308 Virulent challenge strain Laboratory stock 
DCO1 70 bp gene deletion of bhuO (BAB2_0677) with an ahpA3 
kanamycin resistance gene insertion 
This study 
DCO1RC DCO1 with bhuO (BAB2_0677) reconstructed onto the 
chromosome using pNPTS138 
This study 
BHB2 Nonpolar, in frame deletion of dhbC Bellaire 1999 
JFO1 ΔdhbC/ΔbhuO This study 
JFO1RC ΔdhbC/ΔbhuO with bhuO (BAB2_0677) reconstructed 
onto the chromosome using pNPTS138 
This study 
BEA2 Δirr Anderson 2011 
Plasmids   
pGEM-T Easy ColE1-based cloning vector; ampicillin resistance Promega 
pKS + Kan 794-bp aphA3 gene from TnphoA cloned into SalI-HindIII-
digested pBluescript II KS+ 
Kovach 1995 
pNPTS138 sacB-containing counterselection vector; ampicillin 
resistance 
Spratt 1986 
 
 
Table 3.1 
117 
 
 
Table 3.2 Primers used in this study. 
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                     Primers used in this study 
bhuO-1F 5’-GACATTTCGCTGAAGACATA -3’ 
bhuO-1R 5’-GAGCTTACTTTACCGTTGGC-3’ 
bhuO-2F 5’-TCTATGCATCCCACACAGTC-3’  
bhuO-2R 5’-GAGCTGGGAGTCACGGTTCT-3’ 
amp - F 5’-TATTTCGTTCATCCATA-3’ 
amp - R 5’-GTTTTCCAATGATGAGC-3’ 
Kan R 5’-CCACTCCAGCATGAGAT-3’ 
bhuO-3F 5’-ACTGGATCCCGGAGCTGTTTCTATTC-3’ 
bhuO-3F 5’-ACTGTCGACTTCTAAATATGAGTTAA-3’ 
16S Fwd    5’-TCTCACGACACGAGCTGACG-3’ 
16S Rev 5’-CGCAGAACCTTACCAGCCCT-3’ 
dhbC Fwd 5’-GTGCCAAGCTTGGTCTGTACTTC-3’ 
dhbC Rev 5’-CGTGGATTGTTTACCGGC-3’ 
bhuO Fwd 5’-CGGTAGCGAAACCGATTTTGAGAC-3’ 
bhuO Rev 5’-ATGCGCATGGCGAAACTGTT-3’ 
rirA F 5’-GCACCGCAGAAAATGGCCGA-3’ 
rirA R 5’-TGGAACATTCCCGAACCGGA-3’ 
Rev 5’-GAAGGCATTGAGTGCTTCGC-3’ 
Ybak/rirA F 5’-TAAAGGTGAGAAAAGGTTTC-3’ 
Ybak/rirA R 5’-GACGCATGATTATTCCTTTT-3’ 
rirA/bhuO F 5’-GGATAGCTGTGGCCTGAATG-3’ 
rirA/bhuO R 5’-GAGCTGGGAGTCACGGTTCT-3’ 
bhuO/bfr F 5’-GCTTCCGTATCGTCACTTTT-3’ 
bhuO/bfr R 5’-GAGCTTACTTTACCGTTGGC-3’ 
rirA F 5’-GCACCGCAGAAAATGGCCGA-3’ 
rirA R 5’-TGGAACATTCCCGAACCGGA-3’ 
Table 3.2 
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Figure 3.1. The B. abortus BhuO protein shares amino acid homology with HmuD/Q and 
IsdG/I. The Brucella abortus (Ba) BhuO protein shares amino acid homology with the heme 
oxygenases HmuD and HmuQ from Bradyrhizobium japonicum (Bj) and IsdG and IsdI from 
Staphylococcus aureus (Sa) and contains the conserved Asn 7, Trp 67 and His 77 residues 
(shown in larger, bold font) shown experimentally to be important for the heme oxygenase 
activity of  IsdG (Skaar 2004). 
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Figure 3.1 
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Figure 3.2. B. abortus DCO1 produces significantly more siderophore than B. abortus 2308 
in response to iron deprivation. (A) Siderophore production by B. abortus 2308, DCO1 
(ΔbhuO) and DCO1RC (DCO1 bhuO+) following 72 h growth in low iron minimal medium. The 
values on the Y axis represent the levels of catechol siderophore detected by the  Arnow assay 
(Arnow 1937). ** = P < 0.01 for comparisons of the data obtained for these strains in the 
Student’s two-tailed t-test (Rosner, 2000). (B) Iron-responsive expression of dhbC in B. abortus 
2308 and DCO1 (2308 bhuO). ‘Fold induction’ on the Y axis represents the difference between 
the levels of dhbC transcripts detected in RNA preparations from B. abortus 2308 and DCO1 
cultures after 72 h of growth in low iron minimal medium compared to RNA preparations from 
these cultures after growth in low iron minimal medium supplemented with 50 µM FeCl3. 
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Figure 3.2 
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Figure 3.3. B. abortus JFO1 has a growth defect in the presence of heme as the sole iron 
source. Growth of B. abortus DCO1 (2308 ΔbhuO) (squares), BHB2 (2308 ΔdhbC) (circles), 
JFO1 (2308 ΔdhbC/ΔbhuO) (triangles), and JFO1RC (JFO1 bhuO+) (diamonds) in (A) low iron 
minimal medium, (B) low iron minimal medium containing 50µM FeCl3, (C) low iron minimal 
medium supplemented with 50µM FeCl3 at 48 hours post-inoculation, and (D) low iron minimal 
medium supplemented with deferrated 25µM hemin at 48 hours post inoculation. The data 
presented are from one experiment, but representative of multiple experiments (>3) from which 
similar trends were observed** = P < 0.01 and *** = P < 0.001 for comparisons of the data 
obtained for these strains in the Student’s two-tailed t-test (Rosner 2000).  
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Figure 3.3 
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Figure 3.4. rirA and bhuO are cotranscribed as an operon in B. abortus 2308. The start site 
(+1) for the rir-bhuO transcript is located 134 base pairs upstream from the rirA ORF (bold, 
underlined), and the location of an Irr binding motif predicted by Rodionov et al. is denoted as a 
‘ICE Box’ and shown in larger, bold-face type (Rodionov 2004), while the nucleotide sequence 
protected by Irr is shown in a box. Primer sets 1, 2, and 3 denote the intragenic regions used to 
define the transcript and the corresponding lanes are marked on the agarose gel picture below it. 
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Figure 3.5. rirA and bhuO transcription is increased in response to iron deprivation in B. 
abortus BEA2(Δirr). ‘Fold induction’ on the Y axis represents the difference between the levels 
of rirA, bhuO and bhuA transcripts detected in RNA preparations from B. abortus 2308 and 
BEA2 after 72 h of growth in low iron minimal medium compared to RNA preparations from 
these cultures after growth in low iron minimal medium supplemented with 50 µM FeCl3. The 
pattern of  bhuA transcription was included in this figure because this gene exhibits elevated 
expression in response to iron deprivation in B. abortus 2308, and this  low iron-responsive 
induction is dependent upon the presence of  Irr (Anderson 2011). 
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Figure 3.6. Irr binds directly to the rirA promoter in B. abortus 2308 and protects a 28 
nucleotide sequence in a DNase I footprint analysis. The triangle above the lanes indicates 
that the corresponding reaction mixtures contain increasing concentrations (700 ng, 1.4 µg, 2.1 
µg, and 3.5 µg) of recombinant Brucella Irr, and the nucleotide sequences shown to the right of 
the gel photos denote the nucleotides protected from DNaseI digestion in the forward and reverse 
strands of the rirA promoter sequence. 
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Figure 3.6.  
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Figure 3.7. Proposed model for the role of BhuO in allowing the transcriptional regulator 
RirA to recognize heme as an iron source in Brucella.  
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Figure 3.7
  
Chapter 4: Summary and Future Directions 
 The requirement for heme in Brucella 
 The virulence of Brucella abortus within the mouse model of infection is 
dependent on the ability of the brucellae to take in heme during their residence within the host 
macrophage. Many pathogens have heme transporters, but only a few have been shown to be 
important for virulence. To date, only Bordetella pertussis, enterohaemorrhagic Escherichia coli, 
Listeria monocytogenes, and the heme auxotroph Haemophilus influenzae contain heme 
transport systems that contribute significantly to virulence of the organism (Morton 2007, Torres 
1997, Brickman 2007, Jin 2006). The data collected on BhuA and BhuTUV has demonstrated 
that without one or more of these components, the cell is unable to take in heme as an iron 
source, therefore this is the only heme transport system in B. abortus 2308. The original bhuA 
mutant was constructed using a chloramphenicol resistance cassette. Recently the CDC instituted 
new guidelines for this select agent that no longer allows chloramphenicol resistance to be 
introduced into the animal models, and therefore a new bhuA kanamycin resistant mutant is 
currently under construction with the intent to use it as a tool for comparison with the bhuTUV 
mutant in the mouse model of infection. While it seems likely that the absence of bhuTUV in the 
brucellae will produce a similar phenotype, experiments will need to be done to confirm this link 
between BhuTUV and virulence.  
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Unknown heme transport components 
 Encoded within the bhuTUV region, and clearly sharing the same operon (see Figure 2.1) 
are two hypothetical open reading frames (ORFs). The first hypothetical ORF is upstream, 
overlaps bhuT by 44 base pairs and encodes a protein that contains no known homology to any 
other protein. The second hypothetical ORF is located at the 3’ end of bhuV and also lacks 
homology to any other known protein. The reason they are mentioned here is because it is not 
unusual for small hypothetical ORFs to actually encode proteins of unknown function within 
heme uptake operons, and it is possible that these two hypothetical ORFs do in fact serve a 
purpose for heme uptake. One component that is clearly absent in the Brucella heme uptake 
model (see Figure 4.1) is a shuttle to accept the heme once it is transported through BhuU. In 
Shigella, ShuS serves this function, chaperoning the heme to the heme oxygenase, and studies 
with reconstituted membranes have shown ShuS to be required for the heme to be released from 
the cytoplasmic permease (Burkhard 2008). The shuttle, HemS, from Yersinia entercolitica has 
been crystallized and the His-196 is required for functionality of the protein. This histidine is 
highly conserved across the known shuttles (Wilks 2011). While there has been no such protein 
found in Brucella, it is not unheard of for these proteins to only look similar in their native 
conformations, which cannot be searched for in a traditional BLAST search. This hypothetical 
protein is only 138 amino acids long, and therefore cannot have have a His – 196, however it 
does have two conserved H-X-X-H domains that are also known heme binding motifs (Matias 
2002).      
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The complexity of regulation of the B. abortus heme transport genes 
 Of particular interest is the unique placement of the genes encoding Brucella’s heme 
transport machinery on different parts of chromosome II (see Figure 4.2). It is possible that this 
distribution of genes is the result of evolutionary inheritance or perhaps lateral gene transfer of 
the heme transport machinery in parts from other bacteria. While the brucellae do spend most of 
their time isolated within the host macrophage, they are considered facultative intracellular 
organisms because they can survive in the environment between infected animals. 
Evolutionarily, some argue that the second chromosome (which incidently is the one with the 
heme uptake genes) is auxiliary, and that it contains a region of homology with that of 
Bartonella species, suggesting a common ancestor for the “auxiliary replicon” (Batut 2004) . 
Obviously there is an evolutionary benefit to having these in separate loci because bhuA 
and bhuTUV show different patterns of iron-responsive regulation. While we know that iron 
metabolism genes must be carefully regulated in order to maintain a safe homeostasis, perhaps in 
Brucella this seemingly complex web of regulation hints at the importance of the interactions of 
the brucellae with heme in the host. For instance, RirA has been shown to be protective against 
cellular oxidative stress, and an isogenic mutant rirA is more sensitive to hydrogen peroxide than 
B. abortus 2308 (unpublished laboratory observation). Is it possible then that RirA is meant not 
only to protect the brucellae against the oxidative burst of the macrophage as it first enters the 
cell but also to repress iron uptake genes at a time when the detrimental effects of the Fenton 
chemistry due to the combination of iron and oxygen would be most likely?  
The interplay of Irr and RirA hints at two different cellular conditions that the brucellae 
are exposed to in vivo, one that mimics log phase of growth and another that mimics stationary 
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growth phase, with an active iron-responsive regulator under each condition. The more static 
phase would involve entry into the cell in a BCV with trafficking to the ER, and the log phase 
would be seen in the replicative niche of the ER. In a previous study, bhuA was shown to be 
stationary phase – dependent in its expression, and in this report bhuTUV has also shown a 
similar regulatory link. However, while bhuA requires Irr for transcription, bhuTUV is 
transcribed in much higher levels without Irr. This effect of RirA and Irr on bhuTUV expression 
is probably indirect, but what is directly regulating these genes? One possible explanation is 
shown in Figure 4.4. Under high iron conditions in the cell, the presence of RirA would repress 
iron uptake genes (such as siderophore). Because of the availability of iron, heme biosynthesis 
genes would be expressed, causing the heme levels in the cell to increase. Encoded within the 
upstream hypothetical ORF in the bhuTUV locus is a conserved cobalamin riboswitch motif, 
with 233 base pairs of conserved mRNA structure (Vitreschak 2003). Cobalamin, better known 
as vitamin B12, shares the first steps of its biosynthetic pathway with that of heme, and in fact 
has a similar final structure to heme (see Figure 4.3). It is possible that under these conditions, 
heme binds directly to this riboswitch (Lester 2011) and that the altered mRNA conformation 
blocks transcription of the bhuTUV operon. However, under low iron (and low heme) 
physiological conditions, the Irr protein would be stable, both repressing heme biosynthesis in 
the absence of iron and activating expression of bhuA, the outer membrane heme transporter. In 
order to establish a testable model, it is necessary to invoke the presence of a third regulator, 
ChrAS. As mentioned in the Literature Review, ChrAS is a heme-sensing two component 
regulator found in C. diphtheria to activate transcription of both a heme export system and a 
heme oxygenase in the presence of heme (Schmitt 1999; Bibb 2010).  In our model, under low 
iron conditions, BhuA would transport heme into the periplasm of the cell. The ChrS protein 
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embedded in the cytoplasmic membrane would sense the heme and phosphorylate ChrA. In turn, 
ChrA would activate expression of bhuTUV, allowing the heme to be transported from the 
periplasm into the cell (see Figure 4.4). We have some preliminary evidence that ChrA is 
activating bhuTUV and also bhuA, which would provide a feedback mechanism for the increased 
expression of bhuA, possibly allowing for full expression of the heme uptake machinery. 
Alternatively, in Chapter 2, the possibility of an uncharacterized regulator is mentioned. 
This extracytoplasmic function sigma factor is an iron-responsive σ70 protein regulator, and there 
are two such putative proteins in Brucella (RpoE1 and 2).  The paradigm for iron-dependent 
sigma factors is FecI from E. coli which depends on the outer membrane ferric dicitrate 
transporter binding to ferric dicitrate to induce a signal to a plasma membrane protein (FecR) 
which then activates the cytoplasmic FecI to promote transcription of the ferric dicitrate operon 
(Kirby 2001). In fact, in Bordetella the FecIR homologs directly regulate expression of the 
bhuRSTUV genes that encode the inner membrane heme transporter components (King 2005). In 
Brucella, Irr activates the expression of bhuA, and perhaps BhuA binding to heme signals a 
Brucella FecR which then activates the RpoE to promote transcription of the bhuTUV locus.   
 
Brucella must acquire iron from the heme 
 There were two main goals to the research project described in this document: one was to 
identify the inner membrane heme transport components of B. abortus 2308 and the second was 
to determine the contribution of BhuO, a known heme oxygenase, to the iron requirements of the 
Brucella. Because the bhuO mutant strain was still able to grow around heme on an agar plate 
when heme was the sole source of iron and there was no significant phenotype for the bhuO 
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mutant strain compared to B. abortus 2308 in vivo, there is a second heme oxygenase in B. 
abortus 2308. This is not suprising since the closest homologs of BhuO, IsdI/G and HmuD/Q are 
both present in pairs (Skaar 2004, Puri 2006). What is suprising is that these other pairs of heme 
oxygenases share high amino acid sequence homology, whereas multiple NCBI BLAST searches 
using BhuO for comparison were unable to uncover a second Brucella heme oxygenase. In fact, 
all known heme oxygenases were used for comparisons in these NCBI BLAST searches, and still 
there is no likely candidate for this second heme oxygenase based on conserved amino acid 
residues. Searches of the annotated B. abortus 2308 genome yielded a gene whose product was a 
monooxygenase, a common annotation for heme oxygenases. This monooxygenase does not 
contain the conserved asparagine residue near its proximal end, but does have a tryptophan and 
histidine near the distal end of the protein, which in IsdG are known functional sites. Future work 
should target this gene, BAB1_1911, for mutagenesis in a bhuO mutant background to determine 
if the ability to use heme as an iron source has been completely removed. Alternatively, a 
transposon mutagenesis library made in the bhuO mutant may reveal candidates for the other 
heme oxygenase(s) by identifying any mutants with a heme utilization defect.  
 
Unanswered questions about bacterial heme oxygenases 
 It has been shown in mammals that the products of heme degradation, biliverdin and 
bilirubin, perform downstream functions to protect the cell by reducing the inflammatory 
response (Chung 2009). While it has been observed for some time in our lab that there is a color 
change consistent with what has been previously described as the presence of porphyrins in the 
low iron medium containing growing B. abortus strains (Martinez 2005), no data to date has 
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been collected regarding what happens to the products of BhuO. If biliverdin in some form is 
being pumped out of the cell, what could the physiological significance of this be, given that the 
brucellae naturally reside within the mammalian cells? The mammalian HO-1 has been 
implicated in the production of anti-inflammatory signaling (see literature review), perhaps the 
Brucella heme oxygenase products are also released into the mammalian cell and act to “calm” 
the immune response, allowing for the maintenance of a chronic infection. 
 Additionally, a question yet to be addressed in any bacterium but often asked: Is 
exogenously acquired heme incorporated directly into bacterial proteins or is it always broken 
down for iron first? This question would be easiest initially to answer using known heme 
auxotrophs such as Haemophilus influenzae, Porphyromonas gingivalis, and even a close 
relative to Brucella, Bartonella quintana (Hanson 1992, Bramanti 1991, Battisti 2007).   While it 
makes sense to conserve bacterial energy whenever possible and simply use the heme that is 
transported, studies have yet to confirm this.  
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Figure 4.1 Heme transport in Brucella abortus 2308. In keeping with heme transport in other 
bacteria, brucellae utilize a heme–specific membrane transport complex in order to bind heme 
and bring it into the cell for use as an iron source. Once the heme has entered the cytoplasm of 
the cell, a heme oxygenase (BhuO) breaks it down into iron, biliverdin, and carbon monoxide.  
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Figure 4.2 Genetic organization of the B. abortus genes associated with heme uptake and 
utilization. The outer membrane heme transporter is encoded on one part of chromosome II, 
located near a siderophore uptake regulator, the genes encoding the periplasmic and cytoplasmic 
components of heme transport are located elsewhere on chromosome II and the heme oxygenase 
is encoded in an operon with rirA, also separately from the rest and directly upstream from the 
genes encoding the iron storage protein bacterioferritin. This unique separation of genes 
responsible for heme uptake is conserved across the Brucella genomes. The black arrows 
represent all of the genes in each operon.   
147 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 
148 
 
Figure 4.3 The similar stuctures of cobalamin (B12) and heme. Cobalamin and heme share 
the same initial biosynthetic steps, and the overall structures look similar. 
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Figure 4.4 Model of possible regulation of heme uptake genes in B. abortus 2308. 
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Figure 4.4 
